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Zusammenfassung
Die Bestrahlung bewegter Tumore mit einem gescannten Teilchenstrahl bedarf besonderer Tech-
niken, um durch die Bewegung verursachte Unter- und Überdosierungen zu vermeiden. Eine sol-
che Technik ist die atemsynchronisiert unterbrochene Bestrahlung (Gating), mit der man eine
Reduzierung der effektiven Tumorbewegung erreicht. Da diese allerdings nicht völlig kompen-
siert wird, kann es auch hier auf Grund des Interplay-Effekts zu unakzeptablen Dosisverteilun-
gen kommen. Zudem ist ein Bewegungserfassungssystem erforderlich, mit dem Dosisapplikation
und Zielbewegung synchronisiert werden.
In Experimenten und Simulationen wurde die Abhängigkeit des Interplay-Effekts für ver-
schiedene Restbewegungsamplituden von Bestrahlungsparametern dosimetrisch untersucht. Es
konnte nachgewiesen werden, dass insbesondere ein vergrößerter Strahlfokus zu einer signifi-
kanten Reduzierung der Dosisinhomogenitäten führen kann.
Bei der Verwendung von Surrogaten zur Erfassung der Tumorbewegung kann es zu Un-
genauigkeiten durch Fehlkorrelationen kommen. Um diese in zukünftigen Studien dosime-
trisch quantifizieren zu können, wurde ein Phantom, das Thoraxatmung und unabhängige
6D-Tumorbewegung simulieren kann, entwickelt und erfolgreich experimentell validiert.
Schließlich wurden zwei Bewegungserfassungssysteme von VisionRT Ltd. bzw. Anzai Me-
dical Co.,Ltd. evaluiert. Hauptaugenmerk lag dabei auf der Quantifizierung von Gating-
Verzögerungen und auf der Korrelation zu Tumorbewegungen.
Die Ergebnisse dieser Arbeit werden für die Gating-Bestrahlungen von Patienten am HIT, die in
den nächsten Monaten beginnen sollen, verwendet werden. Zudem steht nun ein Bestrahlungs-
phantom zur Verfügung, das viele Einsatzmöglichkeiten bietet und bereits jetzt von mehreren
Forschungsgruppen genutzt wird.
i

Abstract
In treatment of motion affected tumours by means of a scanned particle beam severe under and
over dosage can occur due to the interplay effect. By using gated beam delivery effective target
motion is reduced, but even for the residual motion the interplay effect can lead to unsatisfactory
dose distributions. Furthermore, an appropriate motion monitoring system is essential since
beam delivery has to be synchronized to target motion.
In this work three aspects were investigated to move gating closer towards clinical opera-
tion at Heidelberg Ion-Beam Therapy Center (HIT): Firstly, influences of beam parameters on
dosimetric effects of residual motion were investigated in experiments and simulations. In-
creased focus sizes and reduced iso-energy distances turned out to be an effective method
to gain dose homogeneity whereas reduction of lateral beam position spacing did not show
such an effect. Secondly, to enable systematic studies of mitigation techniques and effects of
miscorrelation between motion monitoring system and tumour motion a phantom with 6D tar-
get and independent thorax motion was constructed and validated successfully in experiments.
Thirdly, two motion monitoring systems by VisionRT Ltd. and Anzai Medical Co.,Ltd., respec-
tively, were compared in terms of gating delays and correlation to tumour motion extracted
from MV-fluoroscopy. While the VisionRT system showed larger delays than the Anzai sys-
tem under laboratory conditions, no significant difference between the systems with respect to
tumour-correlation was found in a clinical study.
Results of this work will be incorporated into patient treatments using gating that will start at
HIT within the next few months. Furthermore, a phantom simulating thorax and target motion
with a variety of applications such as 4D imaging is now available and already in use by several
groups.
iii
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1 Motivation
Cancer is one of the most leading causes of death worldwide. According to the World Health
Organisation (WHO) in 2008 7.6 million died due to it which corresponds to about 13% of all
deaths [WHO]. In Germany in 2006 about 430.000 incidents and about 210.000 cancer related
deaths were reported [RKI].
For about 50% of incidents radiation therapy is a helpful treatment option and has been used
for many years [Schardt et al., 2010]. Within the last twenty years due to physical and biological
reasons (see section 2.1) more promising techniques came up using ions instead of photons or
electrons as a projectile for tumour irradiation. It turned out that ion-therapy can gain higher
tumour conformity and better control rates than conventional photon therapy [Durante and
Loeffler, 2010; Levin et al., 2005; Schulz-Ertner et al., 2007; Tsujii et al., 2004]. Ion-therapy
has the potential to be more precise in targeting. Using ions and especially a certain dose
delivery thecnique, beam scanning, the volume where the dose is applied to can be almost
exactly matched to the tumour volume, which is not the case in photon therapy. This potential
of higher tumour volume conformity leads to less dose in healthy tissue which is one of the goals
of improving radiation therapy [Schardt et al., 2010].
As long as the target stays stationary high volume conformity can be achieved, to accomplish
this goal for moving tumours is a big challenge. Statistics of cancer incidents show that tumours
in moving organs (e. g. lung or liver tumours) occur quite often. Tables 1.1 and 1.2 list the ten
most occurring cancer types and the ten death-causing cancer types, respectively, taken from
data which was published by the International Agency for Research on Cancer (IARC) based
on the year 2008. One can see that lung cancer is the most likely cancer for men. Liver and
stomach cancer which are also affected by breathing are among the top five. In case of women
lung cancer is also one of the more frequent cancers. In terms of mortality it is even number
two.
Some different strategies have been proposed to treat moving organs using ions [Bert and
Durante, 2011]. One of these strategies is to synchronize irradiation with tumour motion and
to gate the irradiation in time intervals when the tumour is at a certain position (gating). This
gated irradiation combines comparable high conformity with comparable low complexity (see
section 2.2.4). So far, gating using a scanned ion beam has not been used clinically, but it
will be the first technique being used at the Heidelberg Ion-Beam Therapy Center (HIT). Goal
of this work was to answer some of the open questions (mitigation of residual motion effects
and motion sensor evaluation) and to develop a phantom for dose verifications and robustness
analysis to bring gating more close to clinical application at HIT.
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Table 1.1.: Cancer incidents worldwide. Numbers are given for the ten most occurring cancer
types for men and women in 2008. Data taken from [IARC]
men women
cancer number ASRa cancer number ASRa
Lung 1092056 34.0 Breast 1384155 39.0
Prostate 899102 28.0 Colorectum 571204 14.7
Colorectum 663904 20.4 Cervix uteri 530232 15.3
Stomach 640031 19.8 Lung 515999 13.6
Liver 523432 16.0 Stomach 348571 9.1
Oesophagus 326245 10.2 Corpus uteri 288387 8.2
Bladder 294345 9.0 Liver 226312 6.0
Non-Hodgkin lymphoma 199736 6.1 Ovary 224747 6.3
Leukaemia 195456 5.9 Thyroid 163968 4.7
Lip, oral cavity 170496 5.3 Non-Hodgkin lymphoma 156695 4.2
All cancersb 6617844 203.8 All cancers b 6044710 165.1
a Age standardised rate per 100.000 per year
b excluding non-melanoma skin cancer
Table 1.2.: Cancer mortalities worldwide. Numbers are given for the ten most cancer caused
deaths for men and women in 2008. Data taken from [IARC]
men women
cancer number ASRa cancer number ASRa
Lung 948993 29.3 Breast 458503 12.5
Liver 478134 14.6 Lung 427586 11.0
Stomach 463930 14.2 Colorectum 288654 7.0
Colorectum 320397 9.7 Cervix uteri 275008 7.8
Oesophagus 276007 8.6 Stomach 273489 6.9
Prostate 258133 7.5 Liver 217592 5.7
Leukaemia 143555 4.3 Ovary 140163 3.8
Pancreas 138377 4.3 Oesophagus 130526 3.4
Bladder 112308 3.3 Pancreas 128292 3.1
Non-Hodgkin lymphoma 109484 3.3 Leukaemia 113606 3.1
All cancersb 4219626 128.6 All cancersb 3345176 87.6
a Age standardised rate per 100.000 per year
b excluding non-melanoma skin cancer
2 1. Motivation
2 Foundations and purpose of this work
2.1 Particle therapy
Basic goal of radiation therapy is to apply a high dose to the tumour by sparing the normal
tissue as much as possible. Conventional photon therapy has been adapted and optimized to
meet this goal. An outmost precision can be obtained by crossfire techniques such as intensity
modulated radiotherapy (IMRT) but on the cost of a higher integral dose to the normal tissue
and longer irradiation times. Ions have properties which make them more advantageous as a
projectile for radiation therapy.
2.1.1 Physical advantage
While photons loose their energy in matter due to the photoelectric effect, the Compton effect or
the pair production effect (depending on the photon energy) [Knoll, 2010], ions follow different
rules. For ions with therapy relevant energies the Bethe-Bloch [Bethe, 1930; Bloch, 1933a,b]
formula describes very well their energy loss (or stopping power) in matter [Nakamura et al.,
2010]:
− dE
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with k1 = 2piNAr2e k2 and k2 = 2mec
2. Projectile dependency is given by its atomic number ZP,
the velocity dependent relativistic factors β and γ and the maximum kinetic energy which can
be transmitted to a free electron in one single collision Tmax, which depends on the projectiles
mass and velocity. Target material impacts stopping power by its charge-over-mass-ratio ZT/AT
([A] = g/mol) and the ionization potential I [Barkas and Berger, 1964; Bichsel, 1992; Stern-
heimer, 1966]. δ
 
βγ

is a density correction [Sternheimer, 1952; Sternheimer and Peieris,
1971; Sternheimer et al., 1984] valid for higher energies. Basically, for a given projectile and
material, the stopping power is only a function of β .
Initial projectile energies relevant for particle therapy are up to about 430MeV/u (carbon
ions) and 230MeV (protons), respectively (βγ ≤ 1). In figure 2.1 for protons and carbon ions
the in radiotherapy more frequently used linear energy transfer (LET) is plotted over a certain
range of particle energy. The LET is the energy loss not normalized to the target density:
3
LET∞ =
dE
dx

keV
µm

(2.2)
While for protons the maximum is at about 0.08MeV/u the maximum in the carbon curve
appears at about 0.35MeV/u. The y-axis, of course, strongly depends on the projectile (Z2P -
dependency) which can also clearly be seen in figure 2.1.
Figure 2.1.: Specific energy loss of carbon ions and protons in water for a therapy relevant en-
ergy range. Nuclear stopping power is indicated for carbon by the dashed line. In
addition, at the top carbon ranges are given [Schardt et al., 2010]. The maximum ap-
pears at higher energies for carbon ions than for protons. In addition, the absolute
values of the carbon curve are higher due to the Z2P -dependency.
If, for instance, a carbon ion with therapeutic initial energy gets slower it first follows the
1/v 2 dominated region of equation 2.1: while velocity decreases stopping power increases.
Once energy gets below some few MeV/u the ion starts to collect electrons. This leads to a
decreased effective charge given by the Barkas formula [Barkas, 1963]
ZP, eff = ZP

1− exp

−125βZ− 23P

(2.3)
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which leads to a decrease of stopping power due to the Z2P, eff-dependency.
In addition, for low energies corrections added as summands within the square brackets of
equation 2.1 get important, namely shell corrections [Barkas and Berger, 1964], the Bloch cor-
rection [ICRU, 1993a] and the Barkas correction [Barkas et al., 1956; Lindhard, 1976].
Electric stopping power below the Bethe-Bloch area was described by [Lindhard et al., 1963]
(behaviour linear to β). This is the region where the particles approximately have the velocity
of the electrons in the target. The maximum in between (compare figure 2.1) is fitted [Andersen
and Ziegler, 1977].
Finally, for very low energies non-ionizing nuclear recoil energy loss starts to dominate the
stopping power (indicated by the dashed line in figure 2.1) [ICRU, 1993a; Lindhard et al., 1963;
Ziegler et al., 1985].
This behaviour of first increasing and, at the last few µm, decreasing dE/dx leads to a depth-
dose distribution with a sharp peak (Bragg-peak). The dose (or absorbed dose) is defined as the
energy absorbed per unit mass
D [Gy] =
∆E
m

J
kg

(2.4)
and, thus, proportional to the energy loss and the particle fluence:
D [Gy] = 1 · 109e dE
ρdx
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MeVcm2
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
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In figure 2.2 depth-dose distributions for two carbon ion energies and two photon energies
are compared. Photon doses show a smooth maximum in little depths (build-up due to forward
scattering of the Compton electrons). After that dose decreases exponentially. Due to the above
discussed aspects carbon shows a sharp Bragg-peak. For both radiation types the position of
the maximum can be shifted to higher depths by increasing initial energy. 25MV is already
the order of maximum available photon energies for therapy (in the Heidelberg clinic typically
6MV beams are used). 270MeV/u is, however, even a low energy for a synchrotron accelerated
carbon beam. While, therefore, the position of the photon dose maximum is limited to a depth
of a few cm a Bragg-peak can easily reach higher depths. Thus, the advantage for treating deep
seated tumours is obvious. In addition, the sharp peak for ion irradiation promises low dose
deposition in normal tissue.
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Figure 2.2.: Depth-dose distributions of 12C (200MeV/u and 270MeV/u), LINAC photons
(25MV) and 60Co photons (1.173MeV and 1.332MeV [BNL]) [Schardt et al., 2010].
The dose maximum moves shifted to higher depth for increasing energy. While ions
show a sharp peak (Bragg-peak) in large depths, photon dose shows a maximum in
little depth and decreases exponentially.
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2.1.2 Biological advantage
Besides the physical differences discussed above there can be biological differences in terms of
dose response dependent on the irradiation type.
Figure 2.3.: Sketch of survival curves for photons and carbon ions. Carbon ions show a much
steeper decrease of survival with dose, thus, they are more effective. The relative
biological effectiveness (RBE) is indicated for 10% and 1% survival and differs for
these two levels [Schardt et al., 2010].
Figure 2.3 shows a potential behaviour of a cell response curve with respect to cell survival.
Sketched is the cell survival over dose (survival curve) for a photon and a carbon beam which
can be parameterized using a linear-quadratic model [Hall and Giaccia, 2011]:
S = e−αD−βD2 (2.6)
The sketch indicates that for a given survival fraction less dose is needed for carbons com-
pared to photons. Thus, for the same dose the biological effect of carbon is higher than for
photons. This enhancement in biological effect is quantified using the so called relative biologi-
cal effectiveness (RBE), which is defined as follows [Hall and Giaccia, 2011]:
RBE=
DPhotons
DTest
(2.7)
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Thus, the RBE is the ratio of the dose needed by a certain test radiation relative to photon
dose leading to the same biological effect. In our case the test radiation would be carbon ion
irradiation.
Due to the low LET of protons RBE for proton irradiation is usually assumed to be 1.1 [Pa-
ganetti, 2003; Paganetti et al., 2002]. For heavy ions, because of the large variation of LET, it is
a more complex situation. RBE depends on several quantities: the biological endpoint (effect),
dose, LET, particle type, and tissue sensitivity [Belli et al., 1998; Furusawa et al., 2000; Schardt
et al., 2010; Suzuki et al., 2000; Weyrather et al., 1999]. Due to this complexity the RBE is calcu-
lated based on a model whereat two different approaches were developed by [Scholz and Kraft,
1996] at GSI and [Kanai et al., 1999] at National Institute of Radiological Sciences (NIRS),
respectively.
An explanation why high-LET radiation can lead to higher biological effects than low-LET
radiation is the track structure: for low-LET radiation a single particle can only transfer a low
amount of energy. Therefore, for photon irradiation lots of photons are needed to deposit the
same dose as a few carbon ions would deposit. This results in higher local effects for carbon
ions while for photons dose is more or less equally distributed. Figure 2.4 illustrates this effect:
a simulated local dose distribution is shown in an area of the typical size of a cell nucleus for
photon and carbon irradiation of different specific energies. The average dose is in all cases
normalized to 2 Gy. One can see that for photons dose is homogeneous while carbon ions show
discrete peaks at single particle tracks. The local doses can be extremely high. The number
of tracks increases with energy, because the energy loss decreases and, thus, fluence has to be
increased to gain the same dose (compare equation 2.5).
Using high-LET irradiation the probability to hit the sensitive volume of a cell, the cell nucleus,
is smaller then using a low-LET irradiation due to the different fluence. But if the high-LET
particle hits the cell nucleus the local dose deposit to a certain part of the nucleus will be much
higher then for low-LET irradiation. Thus, there is the potential to have a higher biological
effect for the same deposit dose.
2.1.3 Treatment planning
To be able to make use of the advantages mentioned above first of all the target has to be identi-
fied. Target definition is done based on a computed tomography (CT). Following [ICRU, 1993b]
several volumes are defined: the gross tumour volume (GTV), the clinical target volume (CTV)
and the planning target volume (PTV). The GTV comprises the macroscopic visible tumour. The
CTV includes besides the GTV all tissue which has, in addition, to be treated. Thus, the CTV
is the volume where the prescribed dose has to be delivered to. To achieve this an additional
margin is added leading to the PTV. This volume comprises the CTV and accounts for any
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Figure 2.4.: Microscopic dose distribution for photons and carbon ions with different specific en-
ergies. Photon dose is homogeneous while carbon dose is locally very high. Fluence
increases with energy due to decreasing LET. Also the maximum local doses decrease
with increasing energy [Scholz, 2003]
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uncertainty arising from patient setup and beam delivery. To ensure that the CTV is treated suf-
ficiently the beam has to be delivered in a way that the entire PTV is covered with the prescribed
dose (PD) (according to [ICRU, 1993b] 100% of the PTV have to be covered with 95% to 107%
of the PD). Based on the CT using the contoured volumes an appropriate treatment planning
system (TPS) optimizes beam parameter in a way that delivery of the resulting plan leads to the
planned dose distribution.
2.1.4 Beam delivery methods
The PD is usually delivered distributed over several days (so called fractions) due to benefits in
respect of repair mechanisms [Hall and Giaccia, 2011]. Furthermore, in each fraction typically
more then one beam incidence angle (so called field) is used to increase the ratio between
target dose and dose in normal tissue. The beam angle relative to the patient can be changed
by rotating the patient couch or rotating the beam by means of a gantry. Pictures of a photon
and ion gantry are shown in figure 2.5.
Figure 2.5.: Pictures of a photon and an ion gantry. (a) Picture of the Siemens Artiste photon
linear accelerator [Siemens]. The whole accelerator (and, thus, the beam) can be
rotated around the patient. Opposite to the beam exit an electronic portal imaging
device (EPID) can measure the beam exiting at the back side of the patient. (b) Beam
line of the Heidelberg Ion-Therapy Center (HIT) [HIT]. Patients can be treated in two
rooms with a horizontal beam and one room where the beam can be rotated around
the patient using the first heavy-ion gantry. (c) Picture of the gantry treatment
room. [HIT]
High-energetic photons (6MV to 24MV) are usually produced by an electron accelerator
where the electrons are stopped in a target. The resulting bremsstrahlung is then laterally
shaped using collimators to adapt it to the beam’s eye view (BEV) projection of the PTV. Due
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to the disadvantageous depth-dose distribution of photons usually 4-7 fields (different gantry
angles) are delivered within one fraction to reduce dose in healthy tissue. Behind the patient ex-
iting photons can be measured using an electronic portal imaging device (EPID) which enables
acquisition of MV-fluoroscopy (see also figure 2.5(a)).
Cyclotrons and synchrotrons, the accelerator types commonly used for production of ion
beams in therapy so far, are primarily providing a pencil beam of ions. Thus, the beam delivery
system has to shape this pencil beam in a way that it deposits dose to the planned volume. An
overview of all potential methods is given in literature [Chu et al., 1993]. The two extreme
forms, the fully passive system (beam scattering system) [Chu et al., 1993] and the fully active
system [Haberer et al., 1993; Pedroni et al., 1995], are explained in the following.
A sketch of a fully passive system is shown in figure 2.6(a). A monoenergetic beam is first
scattered to widen it to the maximum lateral necessary size. After that a range modulator
converts the monoenergetic beam to a beam with a certain spread of energies. Since particle
energy corresponds to particle range at this stage a certain range area can be covered by the
so called spread out Bragg-peak (SOBP). A range shifter then shifts this SOBP to the depth
necessary to cover the tumour. From this point patient specific modulations have to be done: A
collimator ensures that the lateral shape of the beam is formed as the lateral shape of the PTV
in BEV and, finally, a patient specific compensator creates the distal dose cut-off.
Fully active systems use ion optics and the accelerator itself to spread the dose over the tar-
get volume. In planning stage the target is divided in small sub volumes: first it is segmented
into a certain number of slices where each slice corresponds to the range of particles of certain
energy (iso-energy slice (IES)). Each IES is then covered with a grid of desired beam spot po-
sitions (beam position grid). During beam application particles are delivered to a certain IES
by selecting the corresponding initial beam energy. Then by using two dipole magnets oriented
perpendicular to each other the beam is swept over the IES by aiming one beam spot position af-
ter another. Lateral beam shaping using dipole magnets is also called scanning (raster scanning
[Haberer et al., 1993] or spot scanning [Pedroni et al., 1995]). While some scanning systems
(e. g. at GSI) are fully active systems, for instance at Paul Scherrer Institut (PSI) (Switzerland)
energy variation is passively done since there a cyclotron is used. In figure 2.6(b) a sketch of a
fully active system is given.
While in a scattering system using an appropriate range modulator the target dose distribution
is intrinsically homogeneous, for a active system two conditions have to be matched: the lateral
overlap factor (laOF) and the longitudinal overlap factor (loOF) of the beam spots have to be
sufficient. The lateral overlap is defined as follows:
laOF=
FWHMBeam
∆s
(2.8)
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Figure 2.6.: (a) Sketch of a passive beam delivery system (beam scattering). The scattering sys-
tem combined with the collimator shape the beam laterally to the target dimensions.
The range modulator, range shifter and compensator create an energy mix resulting
in a spread-out Bragg-peak (SOBP) covering the target. The proximal edge can not
be adapted to the target dimensions (indicated by the read area representing the
target dose area). (b) Sketch of an active beam delivery system (beam scanning).
The Bragg-peak is directed to each raster position within the target. Range is con-
trolled by the initial beam energy and lateral positioning is done by two deflection
magnets which are oriented perpendicular to each other. Target dose area (read
area) can nicely shaped to the target dimensions.
12 2. Foundations and purpose of this work
where FWHM is the full width at half maximum of the beam spot and∆s is the lateral spacing
of the beam position grid.
On the right hand side of figure 2.6(b) it is indicated that also in such a system some passive
devices are needed. To gain a sufficient overlap of the Bragg-peaks a ripple filter (RiFi) is used.
A RiFi widens the Bragg-peak to a width of some mm. The longitudinal overlap is given by
the Bragg-peak width resulting from the used RiFi [Weber and Kraft, 1999] and the used IES
spacing ∆z:
loOF=
dRiF i
∆z
(2.9)
Studies for stationary targets have been done by [Haberer et al., 1993; Weber, 1996]: Suffi-
cient dose distributions can be reached with laOF= 3 and loOF= 1 [Kraemer et al., 2000]. At
GSI a RiFi adjusted for 3mm IES spacing is used.
An advantage of a fully active system is the much less material in the beam line. In a passive
system lots of the incident particles are absorbed by the beam shaping devices introducing sec-
ondary irradiation (especially neutrons [Binns and Hough, 1997; Yan et al., 2002]). For particles
heavier than protons fragmentation of the primary beam is also an issue. But in an active system
fragmentation can also be present due to nuclear interactions within the patient (Fragments in
the beam are the reason for the dose tail behind the Bragg-peak in figure 2.2). In addition, the
proximal dose gradient can not be shaped with passive devices leading to worse volume confor-
mity of scattering systems compared to the scanning technique (compare figure 2.6 on the right
hand side).
Besides the different beam purity and conformity dose delivery timing is different which has
implications on the irradiation of moving targets: while dose in the passive case is applied to the
whole target volume at one time in the active system it is built up spot by spot. The consequences
will be discussed in section 2.2. It has to be noted that some facilities are able to scan much
faster than it is possible at GSI [Furukawa et al., 2010b; Pedroni et al., 2004; Zenklusen et al.,
2010] which may reduce influences of target motion on the resulting dose distribution.
2.1.5 Status
At the moment 34 sites using ions for cancer treatment are in clinical operation ([PTCOG]).
Three of them use beam scanning (HIT, Heidelberg, Germany [Haberer et al., 2004]; PSI, Villi-
gen, Switzerland [Pedroni et al., 1995, 2004]; Rinecker Proton Therapy Center (RPTC), Munich,
Germany) and two sites both techniques (MD Anderson Cancer Center (MDACC), Houston, USA
[Smith et al., 2009]; NIRS, Chiba, Japan). All the others use the passive beam delivery tech-
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nique, so far. 24 new facilities are currently under construction or in planning stage. Minimum
5 of them will have scanned beam application (for some this information is not available).
Till end of 2010 78275 patients were treated using ions, most of them with protons (67097)
[PTCOG]. So far, moving organs were only treated with ions in facilities using a passive beam
delivery system [Schardt et al., 2010]. The reason for that will be discussed in the next sections.
2.2 Treatment of moving tumours
2.2.1 Causes of tumour motion
Tumour motion can be classified into three types [Bert and Durante, 2011]:
i) patient motion
ii) motion in-between two fractions (inter-fractional motion)
iii) motion within one fraction (intra-fractional motion)
Motion of the patient itself (i) is compensated by immobilization of the patient. For instance
in brain-tumour treatments using ions usually by means of a mask the head is fixed to the
treatment couch. Inter-fractional motion (ii) can occur e. g. in prostate cancer. Prostate position
may change from day to day due to altering filling of bladder and rectum [Chandra et al.,
2003; Langen and Jones, 2001]. Both motion causes are linked to a time scale of some minutes
to hours and, therefore, can be compensated during patient setup as long as treatment time
is short. If the time-scale of the motion is shorter or comparable to the treatment time it is
called intra-fractional motion (iii). Intra-fractional motion is mainly caused by respiration which
affects tumours situated in the thorax or abdomen. For example, for lung tumours motion
amplitudes of up to 25mm were observed while the main motion direction was found to be
the superior-inferior (SI)-direction (motion along the head-feet-axis) [Britton et al., 2007; Koch
et al., 2004; Liu et al., 2004; Neicu et al., 2003; Seppenwoolde et al., 2002; Sonke et al., 2008].
Furthermore, e. g. for liver tumours drifts of the centre of motion (base-line drifts) of up to
6.3mm have been observed [von M. Siebenthal et al., 2007a,b].
Since this work is focused on a technique which mitigates intra-fractional motion all the fol-
lowing refers to that type of tumour motion.
2.2.2 Implications of tumour motion
First implication is obvious: a moving target can leave the PTV if motion is not taken into
account in planning stage. This geometrically displacement can lead to severe under dosage
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of the CTV. Therefore, motion amount has to be estimated and incorporated into treatment
planning which will be briefly discussed in section 2.2.3.
The second effect of motion is correlated to the dependency of the depth-dose distribution
on the initial energy. During respiration e. g. the position of ribs change which leads to altering
composition of the material within the entrance channel. Bones reduce beam energy much
more than inter-rib tissue. Thus, the energy of the beam changes during motion which affects
the range in case of particle irradiation (compare figure 2.2). If particle energy drops too much
it can effect in under dosage of parts of the tumour since in some motion states range does
not suffice to cover the whole PTV. Figure 2.7 shows as an example range changes due to
respiratory motion for a lung cancer patient. The iso-range lines differ a lot between the two
shown breathing phases (maximum inhale and maximum exhale).
Figure 2.7.: Range Changes due to respiratory motion. For two breathing phases (maximum in-
hale and maximum exhale) iso-range lines for ranges of 2 cm to 10 cm are displayed.
[Bert and Durante, 2011]
The third implication occurs in case of particles only for active beam delivery and results
from the time dependency of the beam delivery system: the target is scanned point by point
and slice by slice. If the target moves the effective raster point position relative to the target
will change during irradiating a certain raster point. The beam spot motion interferes with the
target motion and this causes inhomogeneous dose distributions which may be unacceptable in
clinical situations.
Figure 2.8 shows as an example the result of a film irradiation using a scanned carbon beam
for a stationary and a moving case. In both cases the aim was to irradiate vertical stripes which
well worked in the stationary case in figure 2.8(a). In figure 2.8(b) only target motion was
switched on resulting in a strange blackening pattern due to the interference of target and beam
motion. This behaviour is also called interplay effect. Severe under and over dosage can be
the result [Bert et al., 2008; Groezinger et al., 2006; Lambert et al., 2005; Phillips et al., 1992]
which is, by the way, also true for IMRT [Bortfeld et al., 2002; Chui et al., 2003], the most
modern photon therapy.
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Figure 2.8.: Irradiation of a stationary and a moving film with the same plan aiming for vertical
stripes [Groezinger, 2004].
2.2.3 Tumour motion and treatment planning
To evaluate the motion amount first of all a time resolved computed tomography (4DCT) is
acquired [Rietzel et al., 2005]. Based on the CTV contoured in several breathing phases an
additional volume is defined which is the geometrical union of the CTVs in all motion states: the
internal target volume (ITV) [ICRU, 1999]. A margin accounting for setup and beam delivery
uncertainties is then added to the ITV resulting in the PTV.
For some beam delivery techniques the ITV not necessarily has to incorporate the whole target
motion. This is the case if the irradiation is only applied during a fraction of motion states
(gating) or if the beam follows the target (beam tracking). This will be more detailed discussed
in the following section.
Otherwise, in case of particles a pure geometrical union of the CTVs may not be enough due
to the range changes presented above [Rietzel and Bert, 2010].
So far, based on the resulting PTV the TPS then optimizes the plan as it would be done in
a stationary case [Bert and Durante, 2011]. In photon therapy ideas of incorporating full 4D
information into the plan optimization have been published [Nohadani et al., 2010].
2.2.4 Tumour motion and beam delivery
In conventional photon therapy and in ion therapy using the passive beam delivery technique
increase of the PTV can be a solution. If the target, the CTV, in any motion state keeps within
the PTV (and in case of particles range changes are incorporated into the ITV) acceptable target
dose can be achieved. However, dose to normal tissue is highly increased.
In contrast for scanned particle beams increase of the PTV only does not work due to the
interplay effect. Thus, more complex efforts have to be done to mitigate effects of target motion
in scanned particle therapy.
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The simplest approach of the three motion effect mitigation techniques is called rescanning or
repainting [Phillips et al., 1992]. The beam is scanned over the PTV n times by delivering 1/n of
the prescribed dose in each scan. There are several flavours of this technique under investigation
[Furukawa et al., 2007, 2010a; Seco et al., 2009], but the basic principle is always the same: In
each scan a certain interplay pattern is generated. The n resulting interplay patterns can look all
different, which depends on timing issues (synchronization between beam delivery timing and
breathing period [Furukawa et al., 2010a]). Thus, it is possible that these n interplay patterns
of all n scans at the end sum up to a homogeneous dose distribution.
The most complex mitigation technique is beam tracking [Groezinger et al., 2004]. The aim of
beam tracking is to follow the target with the beam and irradiate it as if it would be a stationary
target. Target position is tracked online and fed into the treatment control system (TCS) in real-
time. The TCS then calculates offsets in all three dimensions and adjusts the beam laterally by
changing the scanner magnet settings and longitudinally e. g. by a fast wedge system [Bert et al.,
2007; Chaudhri et al., 2010; Groezinger et al., 2004]. Such a wedge can decrease or increase
the beam energy slightly by putting more or less absorber material in the beam resulting in
different Bragg-peak positions. Beam tracking would gain healthy tissue sparing since as less
healthy tissue is irradiated as it would be in stationary irradiation. The problem with this
technique is the high complexity especially in respect of determining the current target position
in real-time.
Less complexity than beam tracking and less healthy tissue irradiation than for rescanning is
combined in the third approach: gating [Minohara et al., 2000]. The basic idea is to irradiate
the target almost like a stationary one and switch off the beam when the target leaves the target
volume.
Figure 2.9 illustrates the principle: The target motion is tracked using an appropriate motion
monitoring system resulting in a motion signal of the target (top row). On this trajectory a
certain window, the gating window (GW), is defined. The target has to be within the target
volume during that GW. The gating control system which is usually incorporated into the motion
monitoring system generates a gate request signal (second row) which is high while target
motion is within the GW. If the synchrotron has beam available (third row) beam will be
extracted (fourth row). In case of using a cyclotron this last condition is missing since beam can
be extracted during all gating windows.
Rescanning is the most simple of the three techniques. In most flavours no motion monitoring
system is needed. Treatment planning is relating to workflow like for a stationary target, only
the PTV is increased in a way that all motion states of the CTV are comprised. But this simplic-
ity is also the disadvantage of this method: the increased target volume implies irradiation of
healthy tissue. In addition that all n interplay patterns sum up to a homogeneous dose distribu-
tion is not guaranteed. Bad timing combinations can lead to severe interplay patterns also using
rescanning [Furukawa et al., 2010a].
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Figure 2.9.: Sketch of the gating principle: based on a target motion trajectory a gating window
(GW) is defined (first row). Based on that GW a gate signal is generated (second
row) by the gate controller (usually incorporated into the motion monitoring sys-
tem). Beam is actually extracted when the gate signal is high and beam is available
(fourth row). In case of a synchrotron beam is not continuously available (third row)
in contrast to a cyclotron.
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Beam tracking represents the other edge of the spectrum. It is the most complex technique.
A very precise motion monitoring system is essential, because tracking of a target needs exact
knowledge of its position. In addition a 4D treatment planning is necessary. And, at least for
the only implemented pencil beam tracking system [Bert et al., 2007; Chaudhri et al., 2010;
Groezinger et al., 2004], passive systems, the energy degrader, enter the beam line. Due to
the high complexity and lots of open questions e. g. concerning target motion tracking, beam
tracking might be a technique to aim for in long term perspective, but it is not likely to get it in
clinical operation within the next years.
That is different for the last technique: gating. As for beam tracking (and for some rescanning
flavours [Furukawa et al., 2007, 2010a; Seco et al., 2009]) a motion monitoring system is
needed. But the requirements to such a system are less [Rietzel and Bert, 2010]: In contrast to
beam tracking for gating it only has to ensure that the tumour is within the PTV when the beam
is switched on. Normal 3D treatment planning is used typically on the end-exhale phase of the
4DCT. In addition, a smaller PTV compared to rescanning can be used. It has only to have the
size corresponding to the GW which leads to sparing of healthy tissue.
But there are some issues which have to be considered before using gating with a scanned par-
ticle beam clinically: Effective motion within irradiation is reduced by irradiating only within
a certain gating window. Thus, motion effects are reduced, but not vanished. Appropriate
techniques to mitigate effects of residual motion have to be established, which may be less com-
plicated then mitigating effects of larger motion [Bert et al., 2010]. In addition an appropriate
motion monitoring system is needed. To ensure target position within a certain window, cor-
relation of external (motion monitoring system) and internal (tumour) motion, but also timing
issues (probable delays) play a role. For systematic studies of the effects of miss-correlation on
dose results an appropriate phantom can be very helpful. In addition, for clinical application in-
vestigation of available commercial motion monitoring systems is needed to find an appropriate
system.
2.3 Purpose of this work
There are more open questions which have to be answered prior to clinical operation of gating
using a scanned particle beam than the three issues mentioned above (e. g. matching of actual
tumour motion at treatment day compared to motion gathered from the 4DCT some days ear-
lier). But the purpose of this work is to focus on these three tasks: motion effect mitigation of
residual motion within the GW, development and test of a motion phantom and evaluation of
two motion monitoring systems available at HIT.
A detailed introduction into residual motion effect mitigation as well as the results of the per-
formed 3D-motion experiments and gating simulations are presented in chapter 3. In chapter 4
the built motion phantom is described including results of the validation experiments. Finally,
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in chapter 5 a comparison study of the two at HIT available motion monitoring systems, the
VisionRT system (AlignRT®/GateRT®– VisionRT Ltd., London, UK) and the Anzai system (RGS
AZ-733V – Anzai Medical Co.,Ltd, Tokyo, Japan) is presented.
20 2. Foundations and purpose of this work
3 A beam parameter study for mitigation
of residual motion effects
3.1 Introduction
Gating has been successfully used in radiation therapy for many years [Berson et al., 2004; Lu
et al., 2007; Minohara et al., 2000], but, so far, only with photons or passively delivered ions.
Gating helps reducing the amount of target motion, but, thereby, the treatment time is increased
by a factor of 2 to 5 [Li et al., 2005; Tsunashima et al., 2008]. Thus, a gating window (GW)
on the one hand has to be as small as possible to reduce motion as much as possible. But on
the other hand the treatment should be doable within reasonable time which limits the GW to
a minimum size. This minimum size results in a residual motion of the target within the GW.
As described earlier residual motion can be handled using passive beam delivery system by
increasing the PTV comprising an ITV to cover all motion states. In case of scanned particle
therapy this may be not enough since the interplay effect can lead to inhomogeneities due to
residual motion.
[Bert et al., 2009] showed a possibility of mitigating residual motion effects: increased over-
lap. As mentioned in section 2.1.4 for stationary targets a lateral overlap factor (laOF) of 3 and
a longitudinal overlap factor (loOF) of 1 ensures homogeneous dose distributions. If the target
does not move the actually hit beam spot positions are as distant as they were planned result-
ing in a sufficient overlap of the single beam spots. If motion comes into play two neighbouring
beam spot positions relative to the targets coordinate system may have more or less the distance
as planned depending on the actual motion during their irradiation. This leads to a higher or
lower dose at this target region.
To increase the overlap two approaches are possible (compare section 2.1.4):
i) reduction of the lateral grid spacing ∆s and the iso-energy slice (IES) distance ∆z, respec-
tively
ii) increase of beam focus and Bragg-peak width, respectively
Lateral and longitudinal grid spacing can be adapted as input parameters for the treatment
plan optimization. The beam focus can be changed using ion-optical systems within the beam
line and the width of the Bragg-peak is adjustable with application of a ripple filter (RiFi) [Weber
and Kraft, 1999].
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The experimental validation of [Bert et al., 2009] was based on film irradiations and a one
dimensional target motion. Longitudinal changes were introduced using a double wedge system
which is part of the beam tracking system at GSI [Saito et al., 2009].
To get from this basic proof of principle to an applicable knowledge about appropriate beam
parameters for a certain patient with a certain tumour motion, as an intermediate step more
complex beam parameter experiments were needed including detectors capable for dosimetric
evaluations. Furthermore, results of this study should be incorporated into the preparation of
gated patient treatments at HIT.
Thus, for a large variation of beam parameters gating experiments were performed at HIT.
Measured doses were reconstructed and interpolated by simulations. The experimental setup,
the data consistency analysis, experimental results and simulations are presented in the follow-
ing sections.
3.2 Material and methods
3.2.1 Experimental setup
Experiments were performed at the quality assurance cave (QA-cave) at HIT. In several beam
times main data acquisition was prepared. The actual dosimetric beam parameter study was
performed in two successive nights whereas at the day in-between the QA-cave needed to be
cleared due to accelerator experiments at daytime. Therefore setup had to be repositioned each
evening.
Figure 3.1 shows the experimental setup. Experiments were performed using a water phantom
(MP3 water phantom – PTW, Freiburg, Germany) in which an array of 24 pinpoint ionization
chambers (PTW PinPoint® model 30009/30015 – PTW, Freiburg, Germany) was placed. Such a
pinpoint array typically is used for plan verification in heavy ion therapy [Karger et al., 1999].
Instead of placing the pinpoint array stationary at a certain position within the water phantom
it was moved using a robotic arm which motion implementation will be further described in
chapter 4.
The target was moved following a three-dimensional sinusoidal trajectory
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Figure 3.1.: Experimental setup. (a) Shown is the robot holding the pinpoint ionization cham-
ber array within the water phantom. On the bottom the Geiger counter providing
a beam status signal additionally to the one generated by the treatment control
system (TCS) is placed. (b) The Anzai laser and an additional laser distance sensor
(LDS) measure the main motion amplitude of the target motion. The Anzai is used
to apply gating signals to the TCS based on the measured motion.
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using as main motion component a left-right motion with a peak-to-peak amplitude AP of
20mm and a period T of 3 s.
Based on this motion gating signals were generated by means of the Anzai system. Gating
was performed amplitude based with GWs of up to 50% (see also section 3.2.3). Additional to
the Anzai laser a second laser distance sensor (LDS) was used to measure target motion inde-
pendently. Furthermore, using a Geiger counter a beam status signal which was independent
from the one generated by the treatment control system (TCS) was measured.
3.2.2 Monitor calibration and divergent beam
To be able to compare results of the two nights and, in addition, make a comparison to calcula-
tions possible, appropriate calibrations had to be done. This implies two steps:
i) calibration of the used ionization chambers
ii) calibration of the beam monitor
Step one is necessary to calculate the absorbed dose from the charge collected in the ionization
chamber. Ionization chambers are generally calibrated using a reference beam (e. g. 60Co) at
standard conditions (20 ◦C and 101.3kPa). The resulting calibration factor has to be converted
to the non-reference condition the chamber is used in. Protocols for such a calibration can be
found in the literature [IAEA, 2000]. Important in this context is that one correction factor, the
density correction, can change on time scales of hours since also air pressure and temperature
can change even if an air conditioning system is in operation. Thus, this correction factor kp/km
was measured prior to each night using a farmer ionization chamber (PTW, Freiburg, Germany)
and a 90Sr-source.
Since beam monitoring is also done using ionization chambers fluctuations in the air den-
sity also affect the beam monitoring system. Besides measuring the beam position this system
controls the particle numbers delivered to the target. These particle numbers are associated
to machine units (MU) which are calculated from measured charges using a calibration fac-
tor. Since this calibration factor is dependent on air density delivered particle numbers may be
wrong if the system is not calibrated properly. The calibration procedure is described by [Karger
et al., 2010]: A farmer chamber is positioned in a solid water plate at ISO-centre and irradiated
with a homogeneous field. The number of delivered particles Nions is calculated and divided by
the applied MU to get the monitor calibration factor
CMC =
Nions
MU
. (3.2)
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This calibration factor is used to convert planned particle numbers to MU and ensures that
the right particle numbers are delivered to the target.
This calibration was done prior to each measurement shift. However, due to the large setup
(compare figure 3.1) the calibration could not be done in the ISO-centre but ∆zMC = −38mm
closer to the beam exit. Measured dose is proportional to the fluence (compare equation 2.5)
and the fluence depends on the lateral grid spacing. Since the effective lateral grid spacing
changes when changing the measuring position in beam’s direction due to the divergent beam
the measured dose changes, too. The relative dose change can be expressed as follows:
D(z)
D(zISO)
= 1
Â
1+
∆zMC
∆zISO−MX
+
∆zMC
∆zISO−MY
+
∆z2MC
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
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where ∆zISO−MX and ∆zISO−MY are the distances between ISO-centre and the horizontal and
vertical bending magnet, respectively. In case of the HIT QA-cave ∆zISO−MX = 6521.9mm and
∆zISO−MX = 7223.5mm. Thus, in our case in the farmer chamber more dose was measured than
expected leading to a too high calibration factor and, thus, to too less particles in the target.
Therefore, dose results were corrected for this under dosage. In addition, equation 3.3 was
experimentally validated by measuring the resulting dose of the monitor calibration irradiation
plan with the farmer chamber for a ∆zMC of (−40, −38, 0, 93, and 147)mm.
3.2.3 Beam delivery parameters and target volume
All four overlap changing beam delivery parameters were varied: lateral grid spacing ∆s, iso-
energy slice (IES) distance ∆z, focus size (full width at half maximum (FWHM)) and Bragg-
peak width. While the first three are available by requesting different accelerator settings the
last parameter implies exchange of the RiFi [Weber and Kraft, 1999]. Two ripple filters were
used: the "normal" 3mm-RiFi which is also used for patient irradiations and a 2x3mm-RiFi
which consists of two 3mm-RiFis attached perpendicular to each other. It is important that such
a device does not widen the Bragg-peak twice as much as the 3mm-RiFi does. As illustrated in
figure 3.2 for a carbon beam of 250MeV/u using a 3mm-RiFi the Bragg-peak width at 75% of its
maximum is 3.0mm while using the 2x3mm-RiFi this width is 3.9mm. Thus, the (2× 3)mm2-
RiFi may correspond to some kind of 4mm-RiFi.
18 plans were optimized to deliver a target dose of 2Gy to an ellipsoidal ITV with diameters
of (56, 40, and 70)mm (x-,y-, and z-direction). Cuts through the calculated stationary dose
distribution including the ITV margin and pinpoint positions are shown in figure 3.3.
Plans were irradiated with GWs of up to 50% corresponding to a maximum residual motion
of 10mm and motion phases of 0° to 180°. In the first and third row of figure 3.3 pinpoint
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Figure 3.2.: Bragg-peak width of a 3mm-RiFi and 2x3mm-RiFi for a 250MeV/u 12C-beam. Widths
are calculated at 75% of the peak height.
positions for the two corner cases 0° and 180° are plotted over the stationary dose distribution.
The pinpoint positions for the stationary irradiations correspond to the 90° motion state. It can
be seen that some pinpoints leave the target volume during motion. Thus, for the analysis a
CTV was defined as the intersection volume of the moving target volume during motion within
a gating window of 50% with the ITV. Only pinpoints within this CTV were included into the
data analysis which reduces the number of used ionization chambers to 12.
Normally first the CTV is defined and the ITV is then calculated as the union of several mo-
tion states of the moving CTV. The here performed inverse definition of the CTV has practical
reasons. Due to the large amount of parameters and the limited beam time we decided to use a
single plan only for all residual motion amplitudes of a certain beam parameter combination.
The used parameter combinations, the measured GWs as well as the day of measurement are
listed in table 3.1.
3.2.4 Data acquisition
Pinpoint doses were measured using two multichannel dosemeters (MULTIDOS® – PTW,
Freiburg, Germany) which provide 12 input channels each.
Using a Beckhoff EtherCAT system (Beckhoff Automation GmbH, Frankfurt, Germany) the
following data were acquired with a temporal resolution of 1ms:
26 3. A beam parameter study for mitigation of residual motion effects
φ
=
18
0°
φ
=
90
°
φ
=
0°
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Figure 3.3.: Cuts through the stationary dose distribution in beam’s eye view, top view and view
from the right hand side. Intersections are drawn at target position (big white cross)
for three motion phases. The two cases φ = 0° and φ = 180° are the first and last,
respectively, motion state within the gating window. φ = 90° represents the motion
state in the centre of the gating window which is also the position, stationary target
irradiations were performed. The black contour indicates the ITV and the 24 white
markers show the positions of the pinpoint ionization chambers in the three motion
phases.
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Table 3.1.: Measured combinations of lateral grid spacing ∆s, IES-slice distance ∆z, beam focus
size (FWHM), ripple filter (RiFi), and residual motion amplitude.
∆s ∆z focus RiFi Day residual motion
[mm] [mm] [mm] [mm] [mm]
2 3 1 2 3 4 5 8 10 3 2x3 0 1 2 3 4 5 6 7 8 9 10
X X X X 1 X X X X
X X X X 1 X X X X X X
X X X X 1 X X X X X
X X X X 1 X X X X
X X X X 1 X X X X
X X X X 1 X X X X
X X X X 1 X X X X
X X X X 1 X X X X
X X X X 1 X X X X
X X X X 2 X X X X
X X X X 2 X X X X X
X X X X 2 X X X X
X X X X 2 X X X X
X X X X 2 X X X X
X X X X 2 X X X X
X X X X 2 X X X X X
X X X X 2 X X X X
X X X X 2 X X X X
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i) the signal of the additional laser distance sensor (LDS) measuring the main motion com-
ponent of the robot (x).
ii) the beam status signal generated by the TCS
iii) counts of a Geiger counter positioned next to the water phantom to generate an indepen-
dent beam status signal
Full information (all six degrees of freedom) of the robot motion was stored to disk using
dedicated logging software (see also chapter 4). In addition, log files of the Anzai system were
saved which also include beam status information.
To be able to reconstruct the measured dose distributions irradiation protocols are needed
comprising information which raster position was irradiated at which time. This information is
provided by the treatment control system (TCS) which automatically saves beam records.
In addition, using the HIT irradiation progress monitor which is also an EtherCAT system and
provides several treatment and accelerator status signals an independent irradiation protocol
was acquired.
3.2.5 Data consistency analysis
Besides monitor calibration prior each measurement day a film was irradiated with a homoge-
neous square and 15 beam spots corresponding to 3 focus levels for 5 energies ((221, 243, 260,
277, and 294)MeV/u) distributed over the used energy range. The films were registered to ISO-
centre by four holes which were pierced into the film at the position of the laser-cross defining
the ISO-centre in the treatment room. Using a dedicated film analysis framework [Steidl et al.,
2011] the homogeneous square was analysed in respect of film homogeneity index HIF which is
calculated from the mean and standard deviation (SD) of the optical density (OD) in a region
of interest (ROI) of (50× 50)mm2 as follows:
HIF = 1− SDMean . (3.4)
Furthermore, beam spot positions and sizes were calculated.
To check data consistency the beam records were analysed and results for the two days were
compared. Amongst others the actually measured beam focus sizes were extracted from the
beam records and compared to the nominal values for all irradiated plans.
Target motion accuracy was investigated using the robot log files. Actually applied amplitudes
and trajectory shapes were compared to the planned motion. Furthermore, motion periods and
phase shifts were investigated.
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3.2.6 Dose reconstruction
Based on the recorded data dose distributions were reconstructed using the 4D version of the
GSI treatment planning system TRiP [Bert and Rietzel, 2007; Kraemer et al., 2000; Richter
et al., 2010c, 2011]. Dose reconstruction was done as part of the validation of 4DTRiP by Daniel
Richter [Richter et al., 2010b] and is only presented here to motivate that the 4D calculation
reproduces measured data and can, thus, be used for the simulation study presented below.
From the reconstructed dose distributions dose values at the pinpoint positions within the CTV
were extracted and compared to the measured doses.
3.2.7 Simulation study
For all measured beam parameter combinations (all 18 irradiation plans) for a GW correspond-
ing to a residual motion of 0mm to 10mm in steps of 1mm dose distributions were calculated
for four starting phases ((0, 90, 180, and 270) °). For one parameter combination (∆s = 2mm,
∆z = 3mm, focus of 10mm FWHM and 3mm-RiFi) for residual motion amplitudes of (1, 5,
and 10)mm even 30 starting phases were calculated (each 12°). Calculations were based on
the ideal target motion trajectory (equation 3.1) segmented into 22 motion states. Beam deliv-
ery records were simulated using a dedicated software which links motion trace, desired gating
window, irradiation plan, intensity levels which would have been chosen for the corresponding
plan at HIT, and realistic beam delivery timing [Naumann, 2011] assuming a rectangular beam
extraction profile.
3.2.8 Data analysis
Measured dose values were corrected by a factor of 1.011 due to the way beam monitor calibra-
tion was performed (compare section 3.2.2) to enable comparison to calculated dose distribu-
tions. As mentioned above only pinpoints located within the CTV were included in data analysis
which reduces the number of dose values to 12. The standard deviation of these 12 measured
doses was calculated as well as the deviation from the results for corresponding stationary
irradiations and the root mean square (RMS) of the deviation.
Simulation results were compared to the measured data as it was done with the reconstructed
dose distributions: dose values were extracted from the dose distributions at the pinpoint posi-
tions within the CTV and compared to the measurements.
Based on all voxels within the CTV for each case a dose volume histogram (DVH) was calcu-
lated. Amongst other parameters homogeneity and conformity was investigated: According to
[Wu et al., 2003] a homogeneity index
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HID = D2− D98 (3.5)
was analysed where D2 and D98 are the minimum doses delivered to 2% and 98% of the CTV,
respectively. This value represents the steepness of the DVH and is zero in an ideal homogeneous
case. Then the fraction of dose delivered to the CTV was estimated by calculating a conformity
index
CI=
∫
CTV
D(x , y, z)∫
D(x , y, z)
. (3.6)
3.3 Results
3.3.1 Data correction
Figure 3.4.: Dose dependency on the distance from ISO-centre. Plotted are measurements per-
formed with the beam monitor calibration setup and a calculation based on equa-
tion 3.3.
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Figure 3.4 shows the results for the measured doses acquired with the monitor calibration
setup for different distances from ISO-centre. The line shows the calculation according to equa-
tion 3.3. Based on this investigation a dose correction factor for doing monitor calibration
−38mm in front of the ISO-centre (BEV) was based on calculation determined to be 1.011.
3.3.2 Data consistency analysis
Table 3.2.: Film results of the beam quality check. For each day the film measured FWHM in x
and y direction of the beam foci and the HIF is given.
Day focus level 2 focus level 3 focus level 4 HIF
FWHMx FWHMy FWHMx FWHMy FWHMx FWHMy
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
[mm] [mm] [mm] [mm] [mm] [mm] [mm] [mm] [mm] [mm] [mm] [mm]
1 6.4 0.3 6.5 0.5 8.8 0.5 9.2 0.6 10.8 0.3 11.9 0.8 0.98
2 6.3 0.1 6.4 0.4 8.9 0.6 9.0 0.4 10.7 0.5 11.7 1.1 0.98
Table 3.2 shows the results for beam spot sizes and field homogeneity using film measure-
ments. The mean and standard deviation (SD) of focus sizes in x and y direction as well as the
film homogeneity HIF are given. Focus level 2 corresponds to a desired value of 5mm full width
at half maximum (FWHM), level 3 to 8mm FWHM and level 4 to 10mm FWHM beam focus,
respectively.
Results of the focus size analysis based on the beam delivery records are given in figure 3.5.
For each irradiated plan of the two days the mean and the standard deviation of the measured
FWHM of the beam in x and y direction is plotted.
3.3.3 Dose reconstruction
A comparison of measured versus reconstructed dose distributions is given in figure 3.6: for 53
cases the deviation between measured and reconstructed doses is given. The plot shows the
mean and the standard deviation of the differences between doses of 12 pinpoint ionization
chambers within the CTV and 12 corresponding dose values extracted from the reconstructed
dose distribution. The plot shows a systematic overestimation of the dose by the calculation of
1.5%.
3.3.4 Lateral overlap: varying grid spacing
Figure 3.7 shows the relative standard deviation of the 12 pinpoint ionization chambers and,
respectively, dose extraction points of the measurements, reconstructions and simulations. In
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Figure 3.5.: Results of the beam focus analysis based on beam records.
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Figure 3.6.: Comparison between measured and reconstructed doses. The red dashed line indi-
cates the mean of the mean deviations resulting in a systematic offset of 1.5%.
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all four cases with respect to a focus of 10mm results for a lateral grid spacing ∆s of 2mm and
3mm, respectively, are plotted. In addition, linear fits are included into the graphs.
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Figure 3.7.: Relative standard deviation for varying lateral grid spacing. More than one data
point per residual motion amplitude reflects different starting phases.
Figure 3.8 shows the simulation results in respect of homogeneity index HID based on all
voxels within the CTV. Plotted are the same four combinations as described above. Again linear
fits are included into the graphs.
In figure 3.9 for all cases with focus size of 10mm the slope of the linear fit is plotted against
the lateral grid spacing ∆s.
3.3.5 Lateral overlap: varying beam focus
Results for the relative standard deviation of the 12 pinpoint ionization chambers for increased
focus sizes are given in figure 3.10 for the measurements, reconstructions and simulations. Re-
ferring to a lateral grid spacing of 2mm results for a focus size of (5, 8, and 10)mm, respectively,
are shown together with corresponding linear fits.
Figure 3.11 shows results of the homogeneity index HID within the whole CTV for the simu-
lations. The figure displays the same four combinations as described above including linear fits
for the different parameter combination cases.
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Figure 3.8.: Simulations: Homogeneity index for varying lateral grid spacing. More than one
data point per residual motion amplitude reflects different starting phases.
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Figure 3.10.: Relative standard deviation for varying beam focus. More than one data point per
residual motion amplitude reflects different starting phases.
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Figure 3.11.: Simulations: Homogeneity index for varying beam focus. More than one data point
per residual motion amplitude reflects different starting phases.
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As a summary plot the slopes of the linear fits are given in figure 3.12 for all cases with lateral
grid spacing of 2mm for varying focus size.
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Figure 3.12.: Simulations: Slopes of the linear fitted homogeneity indices for varying beam focus.
3.3.6 Lateral overlap: varying slice distance
Also for varying slice distance in figure 3.13 first the results for the relative standard deviation
of the 12 pinpoint ionization chambers are shown with corresponding reconstructions and sim-
ulations. In respect of the two used ripple filters results for IES distances ∆z of (1, 2, 3, and
4)mm are given including linear fits.
Figure 3.14 shows the homogeneity index HID resulting from the simulations. Besides the
values based on the whole CTV linear fits are displayed.
In figure 3.15 for all cases with 3mm-RiFi and 2x3mm-RiFi, respectively, the slope of the
linear fit is plotted against the IES distance.
3.3.7 Lateral overlap: varying ripple filter
Figure 3.16 shows the relative standard deviation of the 12 dose values extracted from the
reconstructed and simulated dose distributions together with the 12 pinpoint measurement re-
sults. For the two ripple filters the eight different combinations are given where the ripple filter
was varied. Linear fits indicate the slope of the behaviour.
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Figure 3.13.: Relative standard deviation for varying slice distance. More than one data point
per residual motion amplitude reflects different starting phases.
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Figure 3.14.: Simulations: Homogeneity index for varying slice distance. More than one data
point per residual motion amplitude reflects different starting phases.
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Figure 3.15.: Simulations: Slopes of the linear fitted homogeneity indices for varying slice dis-
tance.
Simulation results with respect to the homogeneity index HID based on all voxels within the
CTV are plotted in figure 3.17. Besides showing the pure values again linear fits are included.
The resulting slopes of the linear fits are given in figure 3.18 for all cases with 3mm-RiFi and
2x3mm-RiFi, respectively.
3.3.8 Conformity index
The conformity index CI turned out to be independent on grid spacing and ripple filter. Only
changing the focus size leads to differences which are shown in figure 3.19.
40 3. A beam parameter study for mitigation of residual motion effects
residual motion [mm] 
0 2 4 6 8 10
st
an
da
rd
 d
ev
ia
tio
n 
[%
] 
0
5
10
15
20
25 s=3 mm∆
z=2 mm∆
focus=10 mm
residual motion [mm] 
0 2 4 6 8 10
s=3 mm∆
z=3 mm∆
focus=10 mm
st
an
da
rd
 d
ev
ia
tio
n 
[%
] 
0
5
10
15
20
25 s=2 mm∆
z=2 mm∆
focus=10 mm
s=2 mm∆
z=3 mm∆
focus=10 mm
st
an
da
rd
 d
ev
ia
tio
n 
[%
] 
0
5
10
15
20
25 s=2 mm∆
z=2 mm∆
focus=8 mm
s=2 mm∆
z=3 mm∆
focus=8 mm
st
an
da
rd
 d
ev
ia
tio
n 
[%
] 
0
5
10
15
20
25 s=2 mm∆
z=2 mm∆
focus=5 mm
s=2 mm∆
z=3 mm∆
focus=5 mm
S=2,S
S=2,M
S=2,R
S=2,S trend
S=2,M trend
S=2,R trend
S=3,S
S=3,M
S=3,R
S=3,S trend
S=3,M trend
S=3,R trend
RiFi [mm]
3 2x3
simulation
measurement
reconstruction
fit simulation
fit measurement
fit reconstruction
Figure 3.16.: Relative standard deviation for varying ripple filter. More than one data point per
residual motion amplitude reflects different starting phases.
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Figure 3.17.: Simulations: Homogeneity index for varying ripple filter. More than one data point
per residual motion amplitude reflects different starting phases.
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Figure 3.18.: Simulations: Slopes of the linear fitted homogeneity indices for varying ripple filter.
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Figure 3.19.: Simulations: Conformity index for varying focus size. More than one data point per
residual motion amplitude reflects different starting phases.
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3.4 Discussion
Due to the need of performing the beam monitor calibration in front of the ISO-centre (BEV)
and because of the divergent beam fewer particles than planned were delivered to the target.
The calculated correction factor of 1.011 is slightly lower than the measured one (compare
figure 3.4). The slope of the calculated curve differs from the slope of the measured values
which may be due to little influence of scattering which is not included into the calculation.
This difference may introduce a systematic offset of the measured doses. However, since this
difference is far below the expected uncertainty for ion-chamber dosimetry of 3% [Karger et al.,
2010] this effect should be negligible.
Results of the radiographic film irradiated to check the beam quality showed that beam focus
size and field homogeneity stayed constant for the two days during which measurements were
performed. Differences in FWHMx and FWHMy of the beam spots (compare table 3.2) are
originated by the beam delivery system at HIT and were characterized by [Parodi et al., 2010].
Measured focus sizes are about 1mm larger than the planned ones. However, in case of film
measurements it is difficult to estimate the real FWHM of the beam since film response is not
linear and the total blackening depends on the particle number directed to the spot position.
Differences in x and y direction were also found in the beam monitor measurements extracted
from the beam records (compare figure 3.5). For comparison to planned focus sizes one may
associate the asymmetric beam spots with the mean width over all values in x and y direction.
By doing so for focus level 2 (planned size 5mm FWHM) a mean of 5.5mm, for focus level
3 (planned size 8mm FWHM) a mean of 7.7mm, and for focus level 4 (planned size 10mm
FWHM) a mean of 9.7mm results. These values differ from the planned sizes by less than 10%
which is acceptable. Furthermore, the focus sizes stayed constant over all measurements on
both days which is even more important. Thus, beam quality turned out to be comparable on
the two days which makes a comparison of the measurements possible.
Measured doses and reconstructed dose distributions showed good agreement. The little
offset of −1.5% lies within the expected uncertainty of ion-chamber based dosimetry of 3%
[Karger et al., 2010]. This good agreement validates that the 4D capable version [Bert and
Rietzel, 2007; Richter et al., 2010c, 2011] of the GSI’s treatment planning software TRiP [Krae-
mer et al., 2000] can be used to increase the parameter space for the beam parameter study by
simulations.
Variation of the lateral grid spacing ∆s showed only in some cases the expected result. The
standard deviation of the 12 pinpoint ionization chambers turned out to be higher for larger
grid spacing only in two of four cases (∆z = 2mm, 10mm focus, both RiFis in figure 3.7). In
the other two cases (∆z = 3mm, 10mm focus, both RiFis) the simulations showed even in-
creased standard deviation for lower grid spacing while measurements resulted in the opposite
behaviour. This heterogeneous result may occur due to two effects: First reason may be the dif-
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fering number of values for measurements and reconstructions compared to simulations where
more amplitudes and starting phases were calculated. In some cases for measurements and
reconstructions dose values may not be representative for a certain amplitude. This is reason-
able when considering the large variation of relative standard deviations in respect of different
starting phases found for the simulations in larger residual motion amplitudes (compare e. g. fig-
ure 3.7, ∆s = 3mm, 10mm focus, 3mm-RiFi, 10mm residual motion). Second reason seems to
be the small effect of variation in lateral grid spacing on dose homogeneity which was found in
the simulations (compare figure 3.8). Slopes differ only by 3× 10−3 mm−1 to 6× 10−3 mm−1
(compare figure 3.9) which is much lower than slope differences found e. g. for variation of
beam focus size (compare figure 3.12).
Beam focus size turned out to affect dosimetric results substantially. Measurements, recon-
structions and simulations showed in all cases lower relative standard deviations of the 12
ionization chamber values and, respectively, dose values extracted from the calculated dose dis-
tribution for increased beam focus size (compare figure 3.10). This effect was also found for the
homogeneity index (compare figure 3.11) and resulted in differences in the slope of the linear
fit by 1.5× 10−2 mm−1 to 3× 10−2 mm−1 (compare figure 3.12).
Variations in IES distance ∆z showed for a beam focus of 8mm the expected behaviour and
good agreement of measurement, reconstruction and simulation (compare figure 3.13). In the
other cases of the comparison with respect to relative standard deviation only the simulation re-
sulted in larger values for larger∆z. This may again occur due to less data points measurements
and reconstructions are based at. In almost all cases the homogeneity index rises for increased
∆z (compare figure 3.14) resulting in slope changes of 0.4× 10−2 mm−1 to 3.4× 10−2 mm−1
(compare figure 3.15). Only for a focus of 10mm changes were small and comparable to the
ones observed for varying ∆s. However, in two of these cases a change to a ∆z of 1mm and
4mm, respectively, showed again a larger difference. The smaller effect for the large focus
size may occur, because the large focus already leads to robustness which can not further be
improved by reduction of ∆z from 3mm to 2mm.
Exchange of the 3mm-RiFi by a 2x3mm-RiFi does not seem to gain better results. In most
cases for relative standard deviation and homogeneity index observed changes were small (com-
pare figure 3.16 and figure 3.17). Slope changes are lower than 0.5× 10−2 mm−1 (compare
figure 3.18). This little effect may be due to the small increase of Bragg-peak width gained by
the 2x3mm-RiFi compared to the 3mm-RiFi (compare figure 3.2).
The results of the conformity index clearly show the drawback of increasing the focus size:
the size of the volume where dose is delivered to increases which leads to a smaller conformity
index for higher beam focus sizes (compare figure 3.19). If conformity is a criterion for an
acceptable dose distribution which is always true in patient irradiations this effect has to be
considered when increasing the beam focus size.
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In summary the measurements not always showed the same tendencies than the calculations.
If the effect of a particular parameter was large in simulations (increased focus, decreased ∆z)
the same behaviour could be found in measurement results.
It turned out that for lateral beam overlap an increase of the beam focus size seems to be more
efficient than reduction of the lateral grid spacing which differs from the observations of [Bert
et al., 2009]. They reported assuming a 5% level of accepted local film blackening deviation
for an 8mm focus size and 2mm lateral grid spacing (laOF= 4) an acceptable residual motion
amplitude of 0.5mm. Increasing the focus to 10mm (laOF= 5) gained an acceptable residual
motion of about 1.9mm while decreasing the lateral grid spacing to 1mm (laOF= 8) resulted in
2mm allowed motion. In figure 3.10 in the simulations (∆z = 3mm, 3mm-RiFi) for an assumed
acceptable standard deviation of 5% and a lateral grid spacing of 2mm changing the focus from
8mm (laOF= 4) to 10mm (laOF= 5) results in a change in accepted residual motion from
2.5mm to 4mm. The resulting acceptable motion values do not match since [Bert et al., 2009]
did film measurements which can not generally be compared directly to ionization chamber
dosimetry [Spielberger et al., 2003], but the tendency is comparable. In contrast for changing
the lateral grid spacing (compare figure 3.7, simulations,∆z = 3mm, 3mm-RiFi)∆s from 3mm
to 2mm while keeping a focus size of 10mm (change of laOF from 3.3 to 5) even resulted in a
slightly increased accepted residual motion (4mm for ∆s = 3 versus 4.5mm for ∆s = 2). Since
different beam parameter settings were analyzed not directly the same combinations can be
compared. But, anyhow, tendencies clearly seem to differ. Based on the here presented results
one can conclude, that the overlap may not be the parameter to enlarge, but the beam focus.
However, by doing so the increase of the penumbra has to be taken into account which is caused
by a larger focus. This can be relevant in patient irradiations.
Longitudinally a reduction of the IES distance resulted in almost all cases in a more homoge-
neous dose distribution which was also observed by [Bert et al., 2009]. But in contrast to this
work they did not study different ripple filters. However, an increased Bragg-peak width did not
show any effect: The resulting slopes of linear fits increased very little compared to improve-
ments which were observed for larger focus sizes in the lateral overlap investigation. Since this
may be due to the little change in Bragg-peak width caused by the 2x3mm-RiFi compared to the
3mm-RiFi (compare figure 3.2) construction of a really larger ripple filter according to [Weber
and Kraft, 1999], e. g. of 6mm thickness, would be necessary to study effects of Bragg-peak
width on motion robustness further.
A reason for the different conclusion compared to [Bert et al., 2009] might be that they
separated lateral and longitudinal overlap in different investigations while in our case both
effects could interact due to the 3D motion. An indication for that can be found in figure 3.13
where for increased focus not only the homogeneity gets better, but also deviations between
homogeneities for different IES distances ∆z get smaller.
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Thus, the basic effects of the four beam parameters causing overlap were shown. To con-
clude clinical implications like a suggested gating window for a certain parameter combination
treatment planning studies based on real patient data are more reliable. Therefore, these in-
vestigations should be continued using patient data to gain more concrete information about
clinical recommendations. This is why the used analysis parameters, relative standard deviation
and homogeneity index which both indicate homogeneity within the CTV, where chosen: basic
focus was put on showing principle effects. In the other observed analysis parameters these
were also seen, the homogeneity was affected most clearly.
Besides the here presented method to reduce interplay effects caused by residual motion
within the GW other techniques are possible. [Furukawa et al., 2010a] combined gating with
rescanning and used the latter technique for mitigation of the interplay effect. They investigated
dosimetric influences on their mitigation technique also based on a similar array of pinpoint
ionization chambers. Already four rescans showed significant increase of target homogeneity in
their dosimetric study.
For both techniques the capability of mitigating residual motion effects was shown. A com-
parison between these two techniques with respect to under and over dosage as well as target
conformity based on patient data would be interesting. Even a combination of both techniques
can be a promising solution.
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4 A breathing thorax phantom with 6D
target motion
4.1 Introduction
As mentioned in chapter 2 for some treatment techniques dealing with moving tumours an
appropriate motion monitoring system is mandatory. Since additional patient dose can be high
while using fluoroscopy for direct tumour position determination [Shirato et al., 2004] it was
proposed to apply surrogate signals to identify the motion state [Evans, 2008].
If a surrogate signal is used one has to ensure that the correlation between internal tumour
motion and external motion signal is well known. Several groups compared surrogate signals to
the real tumour motion based on patient data [Beddar et al., 2007; Gierga et al., 2005; Hoisak
et al., 2006, 2004; Ionascu et al., 2007; Kanoulas et al., 2007; Liu et al., 2004; Otani et al., 2010;
Tsunashima et al., 2004]. In some cases a good correlation was found, but some groups reported
dependencies on patient, applied surrogate and reference points/marker positions. Phase shifts
(time shifts) were observed as well as organ drifts due to muscle relaxation [Sonke et al., 2008;
von M. Siebenthal et al., 2007a,b]. Studying patient data is necessary to gain the possibility of
judging clinical relevance, but to estimate dosimetric effects of wrong correlation systematically
proper phantoms are needed. Such a phantom can be very helpful for treatment plan validation
and robustness analysis as well as for testing within technical development of new mitigation
techniques or correlation models.
Depending on the studies which shall be done and the aspects which shall be focussed on, we
defined criteria for the minimum functionality of the phantom (non-weighted order):
i) Anthropomorphic, breathing, deformable thorax comprising ribs
ii) Capability to perform 6D internal target motion (without deformation) independently from
thorax motion
iii) Online adjustable correlation between internal target motion and external thorax motion
iv) Capability to start and stop target and thorax motion in any motion phase
v) Detector head representing the tumour equipped with multiple ionization chambers and
films
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vi) External motion applicable to surface imaging (e. g. the VisionRT system (Vision RT Ltd,
London, UK)) and other systems like the Anzai belt (Anzai Medical Co.,Ltd, Tokyo, Japan)
or RPM (Varian Real-time Position Management™ – Varian Medical Systems Inc., Palo Alto,
CA)
vii) 4DCT compliance, e. g. no metal
viii) Extendable I/O signal interfaces, e. g. triggered motion start or beam gate output
ix) High flexibility, e. g. exchangeable detector head
Ribs (i) are necessary to have an inhomogeneous target introducing range changes. The
phantom should be usable for correlation studies (ii,iii) including static (e. g. phase shift) and
dynamic (e. g. baseline drift) correlation mismatches. This introduces the need of changing the
correlation during irradiation. In addition, the target should be movable following any trajec-
tory to introduce also real tumour motion taken e. g. from a 4DCT. Starting and stopping of
target and thorax motion in any motion state (iv) is necessary to perform irradiation experi-
ments with comparable starting phase or for 4DCT acquisition free of motion artefacts (motion
hold in each scanned motion phase). To do dosimetric studies using heavy-ion irradiation volu-
metric dose measurements are needed to measure the interplay effect. Since films offer a very
high spatial resolution, but are not very precise in terms of measuring absolute dose using ions
[Spielberger et al., 2003], in addition to films multiple ionization chambers are needed within
the moving target volume (v) [Karger et al., 1999, 2010]. Surrogate signals should be applied
to the phantom as they would be in patient case (e. g. need of deformable thorax to enable use
of the Anzai belt) and the phantom has to be 4DCT compatible in terms of motion detection and
material (vi,vii). Finally, to trigger phantom motion e. g. to have a dedicated starting phase or
to output a nominal gating signal the phantom should have I/O interfaces which should be as
flexible as possible to cover also future needs. More general requirements for a 4D validation
phantom were published by [Knopf et al., 2010].
There are a few commercial motion phantoms available e. g. by QRM (Sim4D+Thorax-
Phantom – QRM GmbH, Moehrendorf, Germany), MODUS-QA (Qasar respiratory motion phan-
tom – Modus Medical Devices Inc., London, CA), StandardImaging (Respiratory Gating platform
– Standard Imaging Inc., Middleton, WI, USA), CIRS (Dynamic Thorax Phantom – CIRS Inc.,
Norfolk, VA, USA), and RSD (Dynamic Anatomical Respiring Humanoid Phantom – Radiological
Support Devices Inc., Long Beach, CA, USA). Only the last two are capable of doing indepen-
dent internal and external motion, but also these are not matching the requirements mentioned
above (e. g. multiple ionization chambers).
This lack of commercial availability causes also other groups to build own phantoms: For
example, [Alasti et al., 2006; Dietrich et al., 2005; D’Souza et al., 2005; Ford et al., 2003;
Gemmel et al., 2010; Jiang et al., 2003; Keall et al., 2001; Rietzel et al., 2005] used a motion
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stage or moving arm to move radiopaque objects or detectors. Others went a more complex
way by, in addition, introducing anthropomorphic structures or more complex motion [Followill
et al., 2007; Kashani et al., 2007; Li et al., 2005; Nioutsikou et al., 2006; Serban et al., 2008;
Vinogradskiy et al., 2009]. [Biederer and Heller, 2003] even built an artificial thorax to do
breathing motion studies with real animal lungs.
All of these phantoms match one or more of the criteria mentioned above, but there is no
phantom which would cover our needs completely. Thus, in the course of this work a phantom
was designed, built and validated experimentally which covers the criteria mentioned above.
4.2 Materials and methods
4.2.1 The thorax
Basis of the artificial thorax is a commercial artificial skeleton (Skelett Bruce – Teng Long Trad-
ing GmbH & Co KG, St. Pölten, Austria) which consists of polyvinyl chloride (PVC). Everything
but the thorax was removed and all metal components used by the manufacturer to connect
the plastic bones (screws, wires, rods) were exchanged with plastic. After that the thorax was
surrounded by rubber to generate a skin-surface and inter-rib material. Rather than using an-
thropomorphic materials that are bone/tissue equivalent, we chose to use a dedicated lookup
table (LUT) to convert the Hounsfield units (HU) of the CT scan into water-equivalent path
lengths (WEPL) for the use with particle irradiation [Jaekel et al., 2001].
4.2.2 The tumour (detector head)
The tumour is represented by a cube consisting of polymethyl methacrylate (PMMA) which
provides slots for 20 pinpoint ionization chambers (PTW PinPoint® model 30009/30015 – PTW,
Freiburg, Germany) and 5 light proof film cases covering radiographic films (detector head).
We decided to use radiographic films instead of gafchromic films, because the only available
EBT2 films turned out to be not useful for homogeneity measurements using ions [Hartmann
et al., 2010]. Therefore, light proof cases had to be constructed to cover small radiographic
films (Kodak X-Omat V – Kodak GmbH, Stuttgart, Germany). These cases were made of black
PVC plates of 1mm thickness. The plates were cut to a size of (5× 7) cm2. Then each of these
was milled to generate space for a film of (4.6× 6.8) cm2 size. After that a second 5x7cm2 sized
plate of the same material was glued on top of the milled one.
The pinpoints are arranged in 4 rows with 5 chambers each, the films are mounted in between,
in front of the first and behind the last row (BEV) (Figure 4.1(b)). The film cases can easily be
replaced by nonirradiated ones. Reequipping of a set of 5 film cases is doable in less than 10
minutes in a dark room. The films were developed using a standard development machine
4.2. Materials and methods 51
(Kodak X-Omat M35 – Kodak GmbH, Stuttgart, Germany; Agfa Curix 60 – Agfa-Gevaert N.V.,
Mortsel, Belgium).
1 2 3 4 5
beam
Figure 4.1.: Pictures of the detector head. (a) The detector head is shown in irradiation position
within the artificial thorax. (b) Picture of the fully equipped detector head. 4 rows
of pinpoint ionization chambers with 5 chambers per row are used for 3D dosimetry
within the target volume. In between the rows, in front of the first and behind the
last row light-proof film cases are placed (black plates) covering radiographic films.
By distributing 20 pinpoints within the maximum target volume of (5× 5× 5) cm3 3D dose
distributions can be measured. To have additional information on e. g. homogeneity with a
higher spatial resolution the 5 radiographic films can be used. It has to be noted that films
behind a certain pinpoint row are partially covered by the chambers. Therefore, the first film in
BEV can be analysed completely while the last film has a much smaller undisturbed area.
4.2.3 Motion control
Thorax motion
A nylon cord which is attached to the sternum is periodically pulled and released by a stepping
motor (AS1050 (200 full steps per revolution, micro step factor 64) – Beckhoff Automation
GmbH, Frankfurt, Germany) via a lever arm (PMMA). This pulling results in contraction and
deformation of the thorax and, therefore, introduces thorax motion. The stepping motor is
placed at the edge of the base-plate (PMMA) to avoid having metal in the scanning field of the
CT (Figure 4.1(a)).
The motor motion intrinsically is measured by an incremental encoder (1024 increments per
revolution) and, in addition, by a laser distance sensor (Model OD100-35P840 – SICK AG,
Waldkirch, Germany) which measures the distance to the moving lever arm.
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Target motion
Motion of the detector head should be as flexible as possible to be able to simulate com-
plex tumour motion. Therefore, the detector head was mounted to a robotic arm (KUKA KR
5 sixx R850 – KUKA Roboter GmbH, Augsburg, Germany) which was programmed to do mo-
tion synchronized to the thorax motion. The motion trajectory is defined by a list of N points
Pi

x , y, z, rx , ry , rz

, i = 1 . . .N which is executed periodically.
Target motion is intrinsically measured by the encoders of each robot axis and transformed
to a 6D position information in Cartesian coordinates each 2ms. In addition, the SI-motion
(superior inferior) is measured using a second laser distance sensor.
Motion correlation
Thorax and robot motion are both controlled by the robot control system. The stepping motor
is connected to a stepper control device which is integrated in a Beckhoff I/O system (extend-
able, programmable bus terminal system; see section 4.2.4). The stepper controller executes
commands given by the robot controller in real time.
Due to technical constraints controlling fixed or defined varying correlations between thorax
and target motion is divided into two phases: the pre- and the main-run. During the pre-run
target and stepper velocities are calculated and synchronized based on the given Pi and the
planned motion period T . In the main-run motion is periodically executed.
Constant phase shifts as well as phase drifts, i. e. an increase of a phase shift during motion,
and base-line drifts, i. e. drifts of the target motion in inferior direction (x) during motion, can
be performed. In addition, the robot control system can react on connected input signals which
can be used to manipulate motion behaviour online (see also section 4.2.4).
4.2.4 I/O interfaces
Motion Logging
The analogue signals of the two laser distance sensors measuring the stepping motor motion
and one projection of the target motion are directly provided and can be fed into an analogue to
digital converter (ADC) to be logged to file. In our experiments we used a Beckhoff EtherCAT™-
system (Beckhoff Automation GmbH, Frankfurt, Germany) in combination with a Windows PC.
In addition, each 2ms a logging data set L j (t) =

t j, Pj

x , , y, z, rx , ry , rz

is written to an
user datagram protocol (UDP) interface providing the current system clock counter t j and the
current position Pj. Using dedicated software on a Windows PC these position logging data can
be written to file.
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Remote control
Since entering an irradiation cave always takes time the robot software was implemented in a
way that it can be controlled remotely. Remote access is realized using normal TCP/IP network
interfaces and control PCs outside the cave. Only the change of film cases causes the need of
entering the irradiation cave.
Multiple IO
The I/O device described in section 4.2.3 also provides 4 digital inputs and outputs for 24V
TTL signals and 12 digital inputs and outputs for 5V TTL signals. These interfaces can be
customized and are currently used to trigger motion start or feed status outputs into the data
acquisition during measurement. In addition, it can in principle be used to gate the beam.
Figure 4.2 gives an overview how the components work together.
Figure 4.2.: (a) Sketch showing an overview of the phantom system: An artificial thorax includ-
ing rips for generation of range changes is connected to a stepping motor in order
to introduce thorax motion. An easily removable detector head is moved using a
robotic arm in the right lung area of that thorax. As an example mounting of com-
mercial motion monitoring systems is indicated by showing the ANZAI system in this
sketch. (b) Photograph of the setup at GSI showing also the VisionRT system.
4.2.5 Validation experiments
Target motion (robot)
146 robot log files have been analyzed to determine precision of the robotic motion. In all
these cases the robot was moved following a 3D sinusoidal trajectory defined as follows:
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where the peak-to-peak amplitude AP was varied from 2mm to 20mm and the period T was
set to 3 s.
Based on the information in all motion log-files the 3D motion was compared to the nominal
motion amplitudes and shapes.
Thorax motion
Thorax motion was evaluated with the VisionRT system. Since transient effects were expected
due to the deformability of the thorax and potential extension of the cord several long-term tests
were performed. Thorax motion was monitored for durations between 30 and 60 minutes. Re-
producibility was tested by changing behaviour between different motion detection sequences:
Motion was just stopped and restarted between two runs or the lever arm was shortly discon-
nected from the cord and reconnected prior to motion restart. In addition, the time between
motion stop and restart was varied. During all these measurements the tracking point of the
VisionRT system was set to the sternum.
Dosimetry
To allow treatment planning we performed 18 3D CT scans (Somatom Sensation Open –
Siemens AG Healthcare, Erlangen, Germany), one for each motion state every 20 degrees dis-
tributed over one thorax motion cycle (The topogram and one axial slice are shown in fig-
ure 4.4). Thus we generated a 4DCT free of motion artefacts and a higher number of motion
states than normally used for standard 4DCT reconstruction. To ensure having the right HU
values we measured the WEPL of material samples using the PTW Peakfinder™ (PTW, Freiburg,
Germany) and a 200MeV/u carbon beam at Heidelberg Ion Therapy Center (HIT).
Figure 4.3 shows the basic principle of WEPL-measurements: Between two ionization cham-
bers a water tank is varied in thickness. For each thickness the relative ionization measured with
the two ionization chambers is acquired. Result is a depth-dose-distribution in water (Bragg-
curve). This procedure is done with and without a sample in front of the measuring device.
Inserting the sample results in a shift of the Bragg-peak (compare figure 4.3(b)). The WEPL is
then calculated as follows:
4.2. Materials and methods 55
WEPL=
Bragg-peak shift
geometrical thickness
(4.2)
Figure 4.3.: Principle of WEPL-measurements. (a) Sketch of the water column of GSI which works
comparable to the PTW Peakfinder™. Figure by courtesy of D. Schardt. (b) Example
of a WEPL measurement: one Bragg-curve with and one without material in front of
the measuring device.
To generate a CT appropriate for irradiation planning we replaced the HU values with the
ones corresponding to the measured WEPL values [Jaekel et al., 2001].
For the dosimetric test based on the CT a plan was optimized to deliver a homogeneous dose
of 1Gy to a cubic target volume of the size of the detector head (figure 4.5) using a scanned
carbon beam. This optimization was done for two plans one for irradiation of the pure detector
head in air and one for irradiation of the detector head in the thorax. A bolus of 4 cm PMMA
was used to have high enough energies for the optimization. Six types of irradiations were
performed to investigate effects of the single components:
i) static detector head in air
ii) moving detector head in air
iii) static detector head in static thorax
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Figure 4.4.: CT scan of the thorax. (a) Topogram (b) Representative axial slice
iv) static detector head in moving thorax
v) moving detector head in static thorax
vi) moving detector head in moving thorax
The detector head was moved as described in (4.1) using a peak-to-peak amplitude AP of
10mm and a period T of 3 s.
Figure 4.5.: Cuts through the calculated dose distribution of a stationary irradiation. The crosses
indicate the measuring positions of the 20 ionization chambers (projected onto the
particular cutting plane). (a) Beam’s eye view, (b) view from the right hand side, (c)
top view. In (b) and (c) the beam comes from the left
Furthermore, gated irradiation was tested using the ANZAI system to show baseline drift and
phase shift functionality. The effect of a baseline drift was tested by comparing gated irradiation
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with AP = 10mm peak-to-peak motion and a gating window of 50% combined with drifts of
(0, 0.2, and 0.4)mm per period. In case of phase shift shifts between target motion and thorax
motion of 0 and 90 degrees were introduced. Using these shifts a target moving with an peak-
to-peak amplitude of AP = 20mm was irradiated using gating based on the external motion
signal with a gating window of 25%. The VisionRT system monitored the thorax motion in
parallel using the sternum as tracking point location. Whereas the target point in the non-gated
irradiations was set to the centre of the 3D motion, in the gating cases it was set to gating
window centre (minimum of target motion – BEV most left position).
Measured doses were compared to the doses calculated using our in-house treatment plan-
ning system TRiP98 [Kraemer et al., 2000]. To compare also the interplay patterns measured
in the moving cases 4D dose distributions were reconstructed based on beam delivery record,
4DCT and motion trace [Bert and Rietzel, 2007; Richter et al., 2010c, 2011]. Therefore, be-
sides the automatically saved machine beam record the laser signals and the beam status signal
were recorded using a Beckhoff EtherCAT system with 1ms acquisition rate to have a temporal
correlation between beam and motion. Additional signals (e. g. a Geiger counter output) were
also logged in the same system to gather more information than essential to gain redundancy.
Comparison was done according to treatment planning verification at GSI [Karger et al., 1999].
Since the dose gradients can be very steep agreement between measured doses and doses
extracted from the calculated dose distribution is very sensitive on positioning errors. There-
fore, the extraction positions were varied by ±2mm and ±2°, respectively, in all 6 degrees of
freedom around the nominal extraction position to estimate if a potential positioning error oc-
curred. Since pinpoint ionization chambers measuring in high dose gradients can have a high
uncertainty, in addition, comparison was also performed by excluding extraction values where
the standard deviation of calculated doses within the sensitive volume of a chamber was larger
than 2 cGy.
4.3 Results
4.3.1 Motion precision
Target motion (robot)
Figure 4.6 shows a comparison between logged and planned trajectory for two randomly
chosen cases taken from the 146 robot log files which have been analyzed. In some small
amplitude cases near the turning point small dips were observed (figure 4.6(e)). Results of the
amplitude analysis can be found in table 4.1. In all cases the found amplitudes are systematically
a little smaller than the planned ones which is due to the way the robot calculates its motion
path in turning points. This deviation is less then 2% in all measured cases. To check the shape
of the logged trajectories each period of each log data was compared to sinusoidal curves with
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Figure 4.6.: Plots of two randomly chosen cases at random time for a small and a large ampli-
tude. Shown is the planned (red line) and the logged (blue line) trajectory for one
period in x , y and z. In the right top area of each plot a zoomed view to the maxi-
mum area is shown. (a-c): AP = 20mm peak-to-peak motion in x . (d-f): AP = 3mm
peak-to-peak motion in x .
amplitudes adjusted to the measured ones. It was found that in all cases the logged trajectories
differ from a perfect sine by (0.00± 0.09)mm.
The periods derived from the maxima positions in all log files were found to be (3000±3) ms.
Thorax motion
VisionRT data showed in some cases a transient effect in the thorax motion. Depending on the
time the thorax was not moved before starting a new measurement this effect which results in
a shift of signal base line lasts between a few seconds up to about 500 s. By then thorax motion
turned out to be very constant.
Figure 4.7 shows as an example a comparison of VisioNRT measurements of the thorax motion
after a very long (12h) and a very short (10 s) pause between two thorax motions. One can see
the much longer base line drift after a long pause. The spikes at the beginning and the end
of the measured trajectories are due to slight wobbling of the camera tripod which was caused
by entering and leaving the room, respectively. For realistic pauses of a few minutes (in our
dosimetry tests) we observed a signal drift of up to 20% (relative to tracking point motion
amplitudes of about 2mm). After up to 60 s the thorax motion stayed stable.
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Table 4.1.: Results of the amplitude analysis. For each planned pea-to-peak amplitude AP the
number of cases N , the mean measured amplitude AmeanM,i and the maximum deviation
between measured and planned amplitude ∆AmaxP−M,i is given for all three translation
directions i = x , y, z. The measured amplitudes AM,i were compared to the actual
planned amplitudes AP,i which result from (4.1): AP,x = AP, AP,y = AP,z =
1
2
· AP.
AP N A
mean
M,x ∆A
max
P−M,x AmeanM,y ∆AmaxP−M,y AmeanM,y ∆AmaxP−M,z
[mm] [mm] [mm] [%] [mm] [mm] [%] [mm] [mm] [%]
2 4 1.991 0.01 0.5 1.013 −0.02 −2.0 0.983 0.02 2.0
3 16 2.983 0.02 0.7 1.496 0.01 0.7 1.491 0.02 1.3
4 5 3.984 0.03 0.8 1.994 0.01 0.5 1.986 0.03 1.5
5 15 4.975 0.03 0.6 2.485 0.02 0.8 2.470 0.04 1.6
6 5 5.966 0.04 0.7 2.990 0.01 0.3 2.972 0.03 1.0
7 14 6.964 0.05 0.7 3.470 0.03 0.9 3.468 0.04 1.1
8 2 7.960 0.04 0.5 3.955 0.05 1.25 3.960 0.04 1.0
10 19 9.943 0.06 0.6 4.978 0.03 0.6 4.972 0.05 1.0
20 69 19.878 0.14 0.7 9.960 0.06 0.6 9.953 0.08 0.8
Figure 4.7.: Long term VisionRT measurements of the thorax motion. The detected maxima
(black line) and minima (red line) of the measured trajectories are plotted over time.
(a) Motion has been started 12h after the last one was stopped. (b) Motion has
been started right after the last one was stopped.
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4.3.2 Irradiation experiments
WEPL results
Table 4.2 gives the results for the measured WEPL of four used materials: the PVC bones are
made of, rubber which was used to build the inter-rib material, a different PVC the film-cases
consist of, and a radiographic film.
Table 4.2.: Results of water-equivalent path length (WEPL) measurements of phantom material.
Material WEPL
Value Uncertainty
PVC: bony anatomy 1.00 0.02
Rubber: inter-rib material 1.06 0.02
PVC: film cases 1.25 0.09
Kodak X-Omat V film 1.60 0.71
In table 4.3 Bragg-peak shifts of equipped and empty film cases are given. For comparison also
the thickness of one film is written. Even if only 5 film cases are inserted into the detector head,
more cases were built to be able to exchange them fast during measurements. The number in
the first column corresponds to the ID of the measured film case.
Table 4.3.: Results for measured Bragg-peak shifts of empty and equipped film cases. In addi-
tion, the value for one Kodak X-Omat-V film is given.
Film case ID Content Bragg-peak shift [mm]
Value Uncertainty
#2 equipped 2.03 0.07
#5 equipped 1.96 0.07
#12 equipped 2.02 0.07
#16 equipped 1.92 0.07
#15 empty 1.82 0.07
#17 empty 1.77 0.07
#23 empty 1.78 0.07
#25 empty 1.75 0.07
Kodak X-Omat V film 0.24 0.07
Film results
Figure 4.8 shows as an example two sets of irradiated films which were put into the detector
head during the dosimetric test experiments. The upper row shows a static case the lower row
a moving case. The films are numbered as they were placed in the detector head in beam
direction. The static case shows a very homogeneous blackening while an interplay pattern can
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Figure 4.8.: Two film sets irradiated using a scanned carbon beam within the detector head.
Upper row: stationary case showing very homogeneous blackening. Lower row:
moving case showing an interplay pattern. The film number specifies the position
in the detector head (compare figure 4.1(b)). The yellow contours indicate the pin-
point positions of the row in front of a certain film. The shadow of the pinpoint
ionization chambers can be seen in the more distant films.
be seen in the moving case. Because the films are in part covered by the pinpoint ionization
chambers one can see shadows of the chambers on the more distal positioned films.
Dose results
As an example figure 4.9 shows a recalculated interplay pattern. It confirms the assumption
mentioned above. Sharp gradients at least in left-right direction (x) can be seen causing high
sensitivity of dose agreement between measurement and calculation on setup errors. Shifting
and rotating of the extraction position within the calculated dose distribution resulted in a clear
minimum in dose deviation only for a shift in x and for two angles (rotation around y and z axis)
(∆x = 1.1mm, ∆ry = 0.2°, ∆rz = −0.2°). In table 4.4 the measured doses and the deviations
from the planned dose are given. Table 4.5 shows the results for comparison between measured
and calculated doses relative to the measured doses.
Base line drift
An overview of all the measured signals using the Beckhoff EtherCAT system can be seen in
figure 4.10. The target motion drifts to lower values (corresponding to the beam’s eye view
right direction) while the thorax motion stays constant. It can also be seen that within a certain
"beam available gate" the beam is delivered in pulses (slope of Geiger counter signal) within the
gating windows only.
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Figure 4.9.: Exemplary plot of cuts through the recalculated dose distribution of an interplay
(case #2 in table 4.5). The crosses indicate the measuring positions of the 20 ioniza-
tion chambers (projected onto the particular cutting plane). (a) Beam’s eye view,
(b) view from the right hand side, (c) top view. In (b) and (c) the beam comes from
the left. The interplay pattern shows sharp gradients in x (left-right) direction.
Table 4.4.: Results of measured doses compared to planned dose of 1Gy.
# Setup Target Thorax DM [Gy] DM−P [%]
Mean SD Mean SD
1 Detector head only Static – 0.99 0.01 −0.9 0.8
2 Detector head only Moved – 0.93 0.05 −7.5 5.4
3 Phantom Static Static 0.99 0.01 −1.2 0.9
4 Phantom Static Moved 0.99 0.01 −1.3 1.0
5 Phantom Moved Static 0.99 0.10 −0.7 10.0
6 Phantom Moved Moved 0.90 0.18 −10.5 17.7
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Table 4.5.: Results of measured doses compared to extracted ones from calculated dose distri-
butions (mean ± standard deviation). Columns 5 and 6 show results extracted at
the nominal position while in columns 7 and 8 results with shifted/rotated extraction
point are reported (∆x = 1.1mm, ∆ry = 0.2°, ∆rz = −0.2°). For the results in
column 6 and 8, in addition, only extracted values were considered having less than
2 cGy standard deviation of dose within the sensitive volume.
# Setup Target Thorax Relative deviations from calculations [%]
Nominal position Corrected position
SDD ≤ 2 cGy SDD ≤ 2 cGy
Mean SD Mean SD Mean SD Mean SD
1 Detector head only Static – 1.0 1.0 1.0 1.0 0.9 0.9 0.9 0.9
2 Detector head only Moved – −4.4 9.9 −0.4 1.8 1.6 3.3 −1.3 2.6
3 Phantom Static Static 1.3 1.0 1.3 1.0 1.2 1.0 1.2 1.0
4 Phantom Static Moved 0.6 1.4 1.1 1.2 1.0 1.0 1.0 1.0
5 Phantom Moved Static 1.7 7.9 1.0 7.6 1.2 5.8 0.0 4.7
6 Phantom Moved Moved 0.8 7.0 0.8 7.0 1.2 5.1 0.6 4.5
Figure 4.10.: Measured signals using the Beckhoff EtherCAT system.
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Figure 4.11.: Measured doses of the 20 pinpoint ionization chambers in beam’s eye view (BEV)
projection. Values are normalized to the doses measured in the stationary case.
In the top centre of each plot the mean deviation and its standard deviation are
listed. (a) Interplay without drift. (b) Base line drift with 0.2mm per period. (c)
Base line drift with 0.4mm per period. Drift direction was BEV to the right (x).
Figure 4.11 shows exemplarily the results of the doses for the base line drift measurements.
It can be seen that in case of a large base line drift the dose in the chambers placed at the most
right leave at some point the target volume and get less dose.
Phase shift
Analysis of the measurements done using the Beckhoff EtherCAT-system (see also figure 4.10)
showed that the phantom was able to perform shifts between thorax and target motion. For the
two applied phase shifts dose deviations of (2.4± 4.0)% (0° phase shift) and (2.7± 3.3)% (90°
phase shift) relative to the stationary measurements were found.
4.4 Discussion
4.4.1 Phantom construction
The presented phantom has anthropomorphic structure in terms of bony anatomy and water
equivalent inter-rib material and thoracic shape as done by some groups found in literature.
While in our phantom the lungs are filled with air, [Nioutsikou et al., 2006] and [Vinogradskiy
et al., 2009] introduced sponges to represent lung equivalent material. [Serban et al., 2008],
in addition, modelled substructure like bifurcations into the lung sponge. [Biederer and Heller,
2003] even used a real lung. Usage of real organs is not very handy for systematic studies which
may take longer time since durability is limited and exchange of the organ results in the need of
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a new 4DCT. Realistic substructures and tumour composition also makes usage for 3D dosimetry
and complex tumour motion difficult. Therefore, we reduced complexity for the inner thorax
structure to a minimum to focus on correlation and complex target motion. Introduction of
sponge as a lung tissue may be done in a second, improved version of the phantom.
In contrast, bony anatomy which only exists in a few phantoms in literature is important
for our needs to have range changes. [Kashani et al., 2007] combined realistic bony structure
and internal composition, but the thorax can not breath which is important to enable usage
of external motion sensors like the ANZAI belt as they would be used in patient case. There
is one commercial phantom capable of doing thorax deformation according to breathing: the
Dynamic Anatomical Respiring Humanoid Phantom by RSD (Radiological Support Devices Inc.,
Long Beach, CA, US) uses compressed air for breathing and target motion, but it is only capable
of doing 1D motion.
Most phantoms used are only capable to do 1D or 2D target motion. [Serban et al., 2008]
and [Nioutsikou et al., 2006] introduce a 3D motion to their target (tumour) by pushing an
artificial diaphragm. This motion is reproducible, but not predictable/adjustable. [Nioutsikou
et al., 2006] constructed a phantom capable of 3D motion following regular or even irregular
trajectories, but target rotations can not be incorporated to the motion trajectories and the phan-
tom is not able to perform external thorax motion which both can be done with the presented
phantom. There are two commercially available systems providing 3D internal and 1D external
motion: the Qasar Respiratory Motion Phantom (Modus Medical Devices Inc., London, CA) and
the Dynamic Thorax Phantom (CIRS Inc., Norfolk, VA, USA). Only the last one can perform the
motion independently, but the use of e. g. an ANZAI belt is not possible since external motion
is realized by an up-and-down moving platform (Only the ANZAI laser could be used or e. g.
the Varian RPM) and, thus, is not patient like. In addition, the correlation can not be adjusted
during measurement and 3D dosimetry using multiple ionization chambers is not possible with
these two systems.
Dosimetry in reported phantoms is done using thermo luminescent dosimeters (TLDs), radio-
graphic or radio chromic films or ionization chambers. TLDs can not be used for precise interplay
measurements since their dose response depends on LET [Avila et al., 1999; Horowitz, 1990;
Horowitz and Stern, 1990] and energy [Besserer et al., 2001; Bilski et al., 1997]. In addition,
they have to be analysed offline. Films are used by several groups. [Nioutsikou et al., 2006]
even used several films to measure the 3D dose distribution within the target, but without in-
corporating ionization chambers. If ionization chambers are used only one chamber is placed
in the moving target which is not enough to measure interplay patterns using ions. Ionization
chamber stacks are reported by [Karger et al., 1999] and [Lomax et al., 2004] in conjunction
with static dose verification measurements at GSI, HIT and Paul Scherrer Institute (PSI, Villigen,
Switzerland). In these cases the pinpoint ionization chambers are put into water while in our
case they are tight surrounded by PMMA.
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Thus, the phantom presented here differs from all commercial available phantoms and those
presented in literature mainly in two characteristics: Correlation of deformable breathing tho-
rax with a target movable in six degrees of freedom and usage of a combination of multiple
ionization chambers and multiple films for target dose measurements. In addition, it is capable
of triggering external systems (like gating the beam) or being triggered to start moving in a
certain motion state.
4.4.2 Validation experiments
Target motion turned out to be very precise in both timing and positioning. Reproducibility is
better than reported by [Serban et al., 2008] and [Kashani et al., 2007] which is not surprising
if using a robotic system. Trajectory amplitudes are about 2% less than the planned ones but
since this is a systematic and reproducible behaviour by planning for a little larger amplitude
than the aimed one even higher precision can be gained.
Thorax motion showed base line drifts directly after motion start due to transient effects. Since
this effect is dependent on the time between two motion sequences, it can easily be overcome by
ensuring that the motion pauses in between two measurements are short and motion is started
prior to the measurement according to the pause. For usual pauses of a few minutes between
two irradiation experiments we found that it is sufficient to start motion 60 seconds prior to
the irradiation. However, for some experiments it may be necessary to start motion in a certain
motion phase synchronously with the irradiation. In this case the base line drift of thorax motion
can be minimized by keeping pauses between irradiations short. In addition, effects of that base
line drift on the dose result are expected to be small: Results for case number 4 (moved thorax,
static target) in table 4.4 are in good agreement with the results of the two stationary cases
number 1 and 3. Thus, motion of the thorax does not have an effect on dose measured in a
static target at least for the chosen target volume. Due to the thorax motion adaption the thorax
gets compressed in anterior-posterior direction. Therefore, the inhomogeneous material in front
of the target moves mainly in the beam’s direction. In addition, motion is small (sternum moves
a few millimetre). Therefore, dosimetric effects of thorax motion only were expected to be
small. In addition, the target volume compared to the ionization chamber positions is not very
sensitive for small range changing motion. Dosimetric effects of thorax motion only may be
larger once foam is introduced as lung material.
Up to now thorax motion shape can not be changed. To introduce more realistic signals for
external motion sensors it is planned to exchange the controller of the Beckhoff I/O device by a
more intelligent one which then may take over parts of the stepper motion control triggered by
the robot control system.
WEPL results of bone-PVC and inter-rib material turned out to be comparable to water. Since
ribs were introduced to generate range changes a higher WEPL compared to the inter-rib mate-
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rial would be better. Since rubber is also covering the ribs and, therefore, the absolute thickness
of the phantom wall is higher at a rib compared to an inter-rib region, the desired effect of
introducing range changes is yet accomplished. In addition, Bragg-peak shifts of empty and
equipped film cases differ by the shift resulting from one film which is reasonable.
Comparison of measured and calculated doses show very good agreement at least for posi-
tion corrected dose extraction. Setup errors based on positioning lasers of 1.1mm lateral and
0.2° in two angles reasonable. The found deviations are acceptable since [Karger et al., 2010]
reported expected uncertainties of up to 3% for static dose measurements which can be even
higher if inhomogeneous material comes into play. Ignoring ionization chambers within high
dose gradients is common practise in dose verification experiments but there is no threshold or
recommendation published. The results show that ignoring pinpoint ionization chambers based
on a gradient criterion gains better agreement between calculation and measurement. Since
this agreement is also acceptable for the results where all 20 pinpoints were included into the
comparison the phantom turns out to be usable for dosimetric studies.
Base line drift results show consistently that the phantom is able to shift the target during
irradiation. For the larger of the both measured drift velocities the target finally leaves the
target volume. This is why results show a clear under dosage in the most right ionization
chamber row.
Phase shift results showed that the phantom is able to apply shifts between thorax and target
motion. Dosimetric results get worse for an applied shift of 90 degrees compared to a shift of 0
degrees which is reasonable.
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5 Evaluation of two respiratory motion
sensors
5.1 Introduction
Essential for motion synchronized irradiation is obviously knowledge about the current target
position. Therefore, appropriate motion monitoring systems have to be used which are able to
detect the current tumour position in real-time.
One possibility is to monitor internal motion directly using fluoroscopy [Shirato et al.,
2000a,b], ultrasound [Kolen et al., 2004] or electro-magnetic tracking of internal markers
[Seiler et al., 2000]. Fluoroscopy introduces additional dose to the patient [Shirato et al.,
2004]. Ultrasound is for some sites not usable as a direct motion monitor (e. g. lung due to
total reflection) and it needs high skilled interpretation [Evans, 2008]. Finally, internal markers
are highly invasive and introduce uncertainties for treatment planning and beam delivery using
intensity modulated particle therapy (IMPT) [Bert and Durante, 2011]. Because of these draw-
backs several groups investigated methods to monitor target motion indirectly with the aid of a
surrogate signal correlated to breathing motion [Evans, 2008].
Several types of surrogate signals have been under investigation: ultrasound monitoring e. g.
the diaphragm [Xu and Hamilton, 2006], spirometry [Zhang et al., 2003], infra-red reflecting
markers [Keall et al., 2006], infra-red emitting markers [Schweikard et al., 2004], a laser dis-
tance sensors [Tsunashima et al., 2004], breath temperature [Kubo and Hill, 1996], a strain
gauge [Lu et al., 2006b], a pressure sensor [Li et al., 2006] or surface imaging [Hughes et al.,
2009].
Commercially available realizations of the last two types are available at the University Clinic
Heidelberg (UCHD): the Anzai system (RGS AZ-733V – Anzai Medical Co.,Ltd, Tokyo, Japan)
and the VisionRT system (AlignRT®/GateRT®– VisionRT Ltd., London, UK). The Anzai system
consists of a gating control system (GCS) which can be used with a belt comprising a pressure
sensor or a LDS as motion detection system. The VisionRT system uses a stereoscopic camera
measuring the thorax surface motion in 3D based on image reconstruction by dedicated software
(AlignRT® or GateRT®). A region of interest (ROI) at a certain tracking point can be tracked
to get the motion signal on which gating can be based (using GateRT®). The signal quantifies
surface motion along the normal vector of the ROI.
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Aim of this work was to determine which of these two (external) motion monitoring systems
would be "better" with respect to applicability for gated patient irradiations at HIT. [Kubo
and Hill, 1996] phrased how the "better" sensor has to be characterized when they evaluated
different motion sensors with respect to their usability for gating. This work focuses on two
important characteristics mentioned by [Kubo and Hill, 1996]: processing speed and reliability.
Thus, we defined two criteria the comparison of the Anzai system and the VisionRT system
should be based on:
i) Gating delays (potentially shifts of the planned gating window)
ii) Correlation of internal motion and motion surrogate
Delays of the actually sent gating window compared to the planned one (i) result in an un-
wanted phase shift with potential bad implications on the dose distribution. To our knowledge
there is no publication on gating delays of the two systems. Only in the newest manual by Anzai
a maximum delay of 175ms is reported [Anzai, 2011]. Such a delay can cause shifts of a gating
window by e. g. 21° assuming a breathing period of 3 s. Observed tumour motion periods vary
between 2.7 s and 6.6 s [Neicu et al., 2003; Seppenwoolde et al., 2002; von M. Siebenthal et al.,
2007a].
A good correlation between an external motion detection system and internal tumour motion
(ii) is essential if the external system shall be used as surrogate for the internal motion. Differ-
ent groups studied this correlation for different systems: [Koch et al., 2004; Liu et al., 2004]
and [Gierga et al., 2005] evaluated the correlation of skin motion to internal target motion.
[Koch et al., 2004; Liu et al., 2004] based their study on magnetic resonance imaging (MRI)
while [Gierga et al., 2005] tracked radiopaque markers with kV-fluoroscopy. [Beddar et al.,
2007; Ionascu et al., 2007; Kanoulas et al., 2007] and [Tsunashima et al., 2004] compared one
commercial external motion sensor against internal motion using 4DCT [Beddar et al., 2007]
and kV-fluoroscopy, respectively. [Ionascu et al., 2007] used a laser distance sensor (LDS) (LB-
300, KEYENCE Corporation, Osaka, Japan), [Kanoulas et al., 2007] and [Tsunashima et al.,
2004] investigated the Anzai system (laser) and [Beddar et al., 2007] analyzed the Real-time
Position Management™ (RPM) system (Varian Medical Systems Inc., Palo Alto, CA). Two groups
compared two different motion sensors. [Hoisak et al., 2006, 2004] evaluated the correlation
of the signals of a spirometer and an electro-magnetic tracking system (Ascension Technologies,
Burlington, VT, USA) against target motion acquired with kV-fluoroscopy. [Otani et al., 2010]
compared the RPM system with the Anzai system with respect to correlation based on 4DCT
data.
The method for internal motion detection in most cases is kV-fluoroscopy. Since this in-
troduces additional dose to the patient [Shirato et al., 2004] we decided to use the irradia-
tion exiting the patient during conventional photon therapy detected with an electronic por-
tal imaging device (EPID) (MV-fluoroscopy) even if a drawback has to be taken into account:
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MV-fluoroscopy data shows inferior image quality compared to kV-fluoroscopy. Especially the
contrast is worse because for photon energies commenly used for MV-fluoroscopy the photon
absorption coefficient of dissimilar tissues differs less than for lower energies. However, [Meyer
et al., 2006; Richter et al., 2010a; Wilbert et al., 2008] showed that it is possible to track tumour
motion based on MV imaging.
To our knowledge there is no publication comparing the Anzai system against the VisionRT
system. The Anzai system has been used by several groups. For instance, [Li et al., 2006] com-
pared this system to the RPM system based on the correlation score. Amongst others the same
quantity was used by [Hughes et al., 2009] to compare the VisionRT system against spirometry,
which is the only paper so far investigating the VisionRT system with respect to gating.
5.2 Material and methods
5.2.1 Gating delays
For both motion monitoring systems gating measurements have been performed. Both systems
were configured to send a gate signal based on motion of the robotic arm which is described in
more detail in chapter 4 for a gating window GW of 50%. Two series of measurements have
been done, one for each motion monitoring system. The setups for the two cases are shown in
figure 5.1.
In case of the Anzai system the robot was moved along a 3D trajectory which can be parame-
terized as follows:
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with a peak-to-peak amplitude A of 20mm and a period Tt of 3 s. A reflective plate was
mounted at the robotic arm. The motion of the plate (x-direction) was measured using the laser
of the Anzai system and with an additional LDS (Model OD100-35P840 – SICK AG, Waldkirch,
Germany; acquisition rate: 1kHz). 13 measurements have been performed with a duration of
3min to 6min (59 to 105 gates amplitude based). The Anzai system was asked to output a gate
signal between 50% exhale and 50% inhale.
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Figure 5.1.: (a) Setup for delay measurements of the Anzai system. One can see the Anzai laser
and an additional LDS measuring the distance to a reflective plate which was moved
in left-right (x) direction using the robot. (b) Setup for the measurements using the
VisionRT system. In this case a horizontal reflective plane (white box) was moved
in up-down direction. The top surface of the box was tracked using the VisionRT
system. In addition a LDS measured its motion from the bottom.
In case of the VisionRT system robot motion was different since the motion signal generated by
that system is based on the anterior-posterior (AP)-motion of the tracking point corresponding
to the y-direction. Thus, a 1D sinusoidal motion was used
y (t) =
1
2
· A · sin
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2pi
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t

(5.2)
also with A = 20mm and Tt = 3 s. Motion of a horizontal surface mounted at the robotic
arm was tracked by the VisionRT system. The same motion was, in addition, measured using a
LDS. 49 measurements distributed over 5 days have been performed (4min to 6min – 81 to 120
gates). Each day prior to the first measurement the camera system was calibrated, the tracking
point was set and in a pre-run the GW was defined according to the minimum and maximum
amplitude to achieve also a gate between 50% exhale and 50% inhale.
The resulting gate signal as well as the signal of the additional LDS were recorded by a
Beckhoff EtherCAT-system (see also figure 4.10) with a temporal resolution of 1ms.
Based on the measured motion signals and the set gating levels the planned gates were cal-
culated and compared with the measured ones. For each gate a start and a stop delay was
evaluated which were defined as follows:
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∆tStart = t
ON
M − tONP
∆tStop = t
OFF
M − tOFFP
(5.3)
where tM is the measured and tP the planned time of each gate signal’s rising edge (ON) and
falling edge (OFF), respectively.
Figure 5.2.: Setup for the dosimetric phase shift analysis. More details on the used phantom can
be found in chapter 4.
To investigate dosimetric effects of gating delays using the phantom presented in chapter 4
gating experiments were performed at HIT. The setup is shown in figure 5.2. The target compris-
ing 20 pinpoint ionization chambers was moved as described in equation 5.1 with A = 20mm
and Tt = 3 s. A PTV of the size of the detector head was irradiated with a homogeneous dose
of 1Gy using a scanned carbon beam. Gating was based on the laser of the Anzai system mea-
suring the thorax motion. Besides a stationary measurement 11 gated irradiations (GW= 25%
amplitude based) were performed, each with a different phase shift between target and thorax
motion. Phase shifts within an interval of −30° to 10° with an increment of 5° and, in addition,
shifts of 90° and 180° were measured.
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To support the results, simulations were performed with the aid of 4DTRiP [Bert and Rietzel,
2007; Richter et al., 2010c, 2011]. Based on the data used for treatment delivery dose dis-
tributions were calculated with phase shifts of 0° to 360°. Within the intervals of −50° to 10°,
70° to 90°, and 160° to 180° shifts were varied using a step size of 1°. In all other intervals a 5°
increment was used. Simulations were done without accounting for a potential motion monitor
delay.
To be able to compare simulations to measurements it has to be taken into account that
measurements were biased by an Anzai gating delay. Therefore, the RMS of the deviations of
all measured phase shifts from the corresponding calculated ones for delays ∆φl of 0° to 20°
(0ms to 167ms) was calculated as follows:
RMS∆φl =
s
1
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2
(5.4)
where N = 11 is the number of measured phase shifts, SDMφk is the standard deviation of the
mean measured doses of the 20 pinpoint ionization chambers and SDC
φk−∆φl is the standard
deviation of the mean calculated doses of 20 extraction positions corresponding to the pinpoint
measurement positions within the dose distribution. The delay ∆φl for which the RMS was
smallest was assumed to be the occurred gating delay.
5.2.2 Correlation
Preparation experiments
The second part of the sensor comparison was based on a correlation study. MV-fluoroscopy
was used to gather motion trajectories from tumours temporally synchronized to the motion
traces acquired with the Anzai system and the VisionRT system. At UCHD in one treatment
room a Anzai system and a VisionRT system are available. In addition, the linear accelerator
(LINAC) (Artiste®(Siemens AG, Erlangen, Germany)) which is installed in that room provides
functionality to record MV-fluoroscopy based on the treatment beam.
Prior to patient measurements temporal correlation and fluoroscopy frame rate was investi-
gated using a sliding table comprising radiopaque markers (screws), a moving reflective surface
for the VisionRT system and a spring generating a pressure signal on the load cell of the Anzai
system during phantom motion. The phantom is shown in figure 5.3. Motion was tracked with
the VisionRT system, the Anzai system, fluoroscopy, and an additional LDS. Temporal synchro-
nization was done using the beam status output of the LINAC which was fed into the VisionRT
system and Anzai system. The LDS measurement was temporally synchronized by means of a
Geiger counter.
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Figure 5.3.: Sliding table phantom. (a) On a base plate a movable plate is mounted (both made
of PMMA) which can perform sinusoidal motion driven by an electric motor. Five
screws are positioned in the middle of the moving plate representing radiopaque
markers. On the right hand side a holder for the Anzai load cell is mounted. During
motion a spring applies pressure on the load cell. Motion is measured using the LDS.
(b) Sliding table in setup position with mounted reflective surface which is tracked
by the VisionRT system. In the background the Geiger-counter is visible. At the left
side the mounted Anzai load cell can be seen.
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Four different voltages were applied to the driving motor resulting in four periods. In addi-
tion, two amplitudes ((26.0, and 17.8)mm) were chosen. In all cases the irradiation time was
identical (150MU using a dose rate of 300MU/min).
An analysis software was implemented which extracted the marker motion from the fluo-
roscopy sequences and compared the resulting trajectory to the three sensor signals [Steidl
et al., 2010]. Frame rates were calculated based on extracted periods and general data acquisi-
tion (DAQ)-functionality was tested.
Patient study
After this DAQ-test patient measurements could be started. Criteria for including patients into
the study were defined as follows:
i) isolated tumour in the lung
ii) sufficient tumour motion judged by the physician
iii) treatment at the Artiste® in 1 to 5 fractions
Criterion (i) was necessary to increase the chance of tracking the tumour in the MV-
fluoroscopy sequences. It was expected that an isolated tumour surrounded by low-density lung
tissue might be clearer visible in MV-images compared to a tumour surrounded by high-density
tissue (e. g. liver tumours). Criterion (ii) originates from the opinion that correlation analysis
does only make sense if sufficient motion is present. With criterion (iii) normal fractionation
and IMRT was explicitly excluded to get fluoroscopy sequences of a reasonable duration (sev-
eral breathing cycles). Within the last two years of the here presented work five patients could
be included into the correlation study. Additionally to the normal treatment the Anzai-belt was
used following the standard protocol: the belt was put around the abdomen except for patient
three (see also table 5.1) where due to an applied abdominal compression the belt was adopted
around the breast. Furthermore, the VisionRT system tracked the motion of the sternum and
the EPID recorded MV-fluoroscopic sequences. The number of fractions and fields as well as the
number of acquired data sets are listed in table 5.1.
The number of data sets differs significantly from the theoretical number which would be the
fraction number multiplied by the field number. This results from problems which occurred
during data acquisition: In some cases the EPID could not be used due to safety issues which
reduces the number of fluoroscopic sequences. For some fields the VisionRT system’s field of
view was covered by the gantry. Thus, it was not able to monitor the patient in these cases. In
addition, the VisionRT system and the Anzai system in some cases due to software and hardware
failures did not save the beam status signal which makes a temporal correlation impossible. The
remaining number of correlated data sets is given in the last three columns of table 5.1. The
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Table 5.1.: List of the acquired patient data. For each patient the number of fractions, fields
per fraction, fluoroscopy sequences (F), Anzai data sets (A) and VisionRT data sets
(V) are given. In addition the number of correlated sets per patient are shown in the
three last columns (Fluoroscopy versus Anzai (F/A), Fluoroscopy versus VisionRT (F/V)
and Anzai versus VisionRT (A/V)). The number in parentheses includes cases with no
beam status signal.
ID Fractions Fields Anzai (A) Fluoro (F) VisionRT (V) A/V A/F V/F
1 3 6 15 3 15 15 3 3
2 1 7 1 1 0 (1) 0 (1) 1 0 (1)
3 5 7 29 29 0 (19) 0 (19) 29 0 (19)
4 3 7 4 2 2 2 2 0
5 3 6 3 3 0 (1) 0 (1) 3 0 (1)
numbers in parentheses include cases of the VisionRT system without beam status signal which
have been analysed anyhow (see below).
Prior to analysing the correlation of the three motion signals tumour motion had to be ex-
tracted from the fluoroscopy sequences. Therefore, the software which was implemented for
the phantom study presented above [Steidl et al., 2010] was extended to handle also patient
data. The implementation was performed during the diploma thesis of Romain Brevet [Brevet,
2011] which was supervised in the course of the here presented work. [Brevet, 2011] also ana-
lyzed correlation scores of the VisionRT system and Anzai system with respect to the extracted
tumour motion. Since this analysis showed phase shifts which were not incorporated into the
analysis, phase shift investigation and correlation analysis was redone based on the previously
extracted tumour motion traces. According to [Lu et al., 2006a] minima and maxima were
estimated for all three types of data. Based on these extrema the phase shifts φMM where cal-
culated. For the pure signals which were only matched by the beam status signal and for the
signals which were additionally corrected for the phase shifts φMM the correlation coefficient
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was calculated where f (t) and g(t) are two signals to compare.
Since in one case the correlation coefficient (CC) drops significantly after applying the phase
shift φMM phase shifts were optimized to investigate for all cases if the extrema based deter-
mination of φMM leaded to the right shift. To do so for phase shifts of ±1/4 of the maximum
observed breathing period (±1700ms) around φMM a maximum search of CC was performed.
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The resulting optimum phase shift φCC corresponding to the maximum CC was estimated. Be-
sides phase shifts in some signals base line drifts and jumps were observed. To estimate their
implication on the resulting CC the signals were normalized period by period to the local am-
plitude range as defined by [Lu et al., 2006a] and the CC for these normalized signals was
calculated, too.
To increase the number of comparable cases also the VisionRT data without beam status signal
was analysed. For cases where Anzai with beam status and fluoroscopy were available the
VisionRT signal was shifted against the two other signals with a resolution of 1ms and the CC
of VisionRT versus Anzai and VisionRT versus fluoroscopy, respectively, were calculated. The
phase shift between Anzai and fluoroscopy was set to φMM. Three global shifts φ
NB
CC where
estimated: One for a maximum CCV vs. A, one for a minimum CCV vs. F (minimum because it is
anti-correlated), and one for the maximum of CCV vs. A+ |CCV vs. F|.
5.3 Results
5.3.1 Gating delays
As a summary the mean and the SD of the 13 measured cases as well as the total minimum and
maximum delay of all investigated GW is given in table 5.2 for ∆tStart and ∆tStop, respectively.
Table 5.2.: Measured gating delays of the Anzai system. Besides the total number of measured
cases NM the number of gating windows NGW, the sampling interval (SaI) and for
start and stop delay (∆tStart and ∆tStop, respectively) the minimum, maximum and
mean of the delay is given.
NM NGW SaI ∆tStart ∆tStop
Mean SD Min Max Mean SD Min Max
[ms] [ms] [ms] [ms] [ms] [ms] [ms] [ms] [ms]
13 59–105 25 100 24 44 165 103 23 42 152
Since in case of VisionRT results turned out to be day specific for each day they are sum-
marized in table 5.3. The total maximum delay of all analyzed GW was 265ms (∆tStart) and
260 (∆tStop), respectively.
Detailed results of gating delays for Anzai and VisionRT can be found in the appendix (sec-
tion A.1 and section A.2).
Figure 5.4 shows the results for the phase shift measurements and simulations. In fig-
ure 5.4(a) the measured doses of the 20 pinpoint ionization chambers relative to the stationary
measurement are plotted over the applied phase shifts. The measured phase shift of 90° turned
out to be the worst case while the result of a phase shift of 180° is comparable to the results for
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Table 5.3.: Measured gating delays of the VisionRT system. For each day the number of measure-
ments NM, the number of gating windows NGW, the sampling interval (SaI) and the
mean, minimum and maximum start (∆tStart) and stop (∆tStop) delay, respectively, is
listed.
Day NM NGW SaI ∆tStart ∆tStop
Mean SD Mean SD Min Max Mean SD Min Max
[ms] [ms] [ms] [ms] [ms] [ms] [ms] [ms] [ms] [ms]
1 10 90–120 80 1 162 6 93 265 144 14 75 260
2 9 90–117 74 1 119 12 54 188 124 16 63 201
3 8 81–112 74 0 118 10 59 170 105 9 45 155
4 11 93–119 74 0 133 7 77 195 126 6 72 196
5 11 87–112 79 1 129 7 66 230 149 8 81 256
phase shifts around 0°. In figure 5.4(b) the SD of the measured doses are plotted together with
the results from the phase shift simulations. Simulation results are additionally shifted by −11°
since for a gating delay of ∆φl = 11° the resulting RMS was smallest.
Figure 5.4.: Results of the measured and simulated phase shifts. (a) Measured doses of the 20
pinpoint ionization chambers relative to the stationary case. (b) Measured and sim-
ulated standard deviations of the 20 pinpoint ionization chambers. Simulations are
additionally shifted by −11°.
5.3.2 Correlation
Preparation experiments
Tracking of the radiopaque marker and, thus, phantom motion extraction from the MV-
fluoroscopy sequences worked very well. The resulting periods of Anzai system, VisionRT
system, LDS, and fluoroscopy are given in table 5.4.
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Table 5.4.: Results of preparation measurements of the correlation study. Shown are the mean
and standard deviation (SD) of the resulting periods in seconds and in case of fluo-
roscopy in frames (f).
# Motor voltage Amplitude Anzai VisionRT LDS Fluoroscopy
Mean SD Mean SD Mean SD Mean SD
[V] [mm] [s] [s] [s] [s] [s] [s] [f] [f]
1 5 26.0 5.37 0.01 5.37 0.01 5.37 0.01 67.1 0.2
2 5 17.8 5.41 0.01 5.40 0.01 5.41 0.02 67.5 0.7
3 5 17.8 5.40 0.01 5.41 0.02 5.40 0.04 67.6 0.1
4 7 26.0 3.75 0.01 3.76 0.01 3.74 0.05 46.9 0.3
5 7 17.8 3.67 0.04 3.67 0.01 3.66 0.02 45.8 0.2
6 9 26.0 2.75 0.01 2.75 0.02 2.75 0.01 34.4 0.1
7 9 17.8 2.76 0.06 2.76 0.01 2.76 0.05 34.5 0.1
8 12 26.0 2.02 0.04 2.02 0.04 2.02 0.02 25.1 0.0
9 12 17.8 2.01 0.01 2.02 0.01 2.01 0.01 25.2 0.1
Based on these periods frame rates of the fluoroscopy sequences were found to be
(12.5± 0.2) fps. The motion amplitude extracted from the fluoroscopy sequences was plot-
ted together with the other three signals for visually inspection. As an example figure 5.5 shows
the plot of measurement #7 which is representative for all cases.
Patient study
Figure 5.6 shows as an example results for the extrema detection within the patient breathing
motion traces. Positions of minima and maxima and the mean local amplitude are plotted (red
line). Extrema were nicely detected by the algorithm reported by [Lu et al., 2006a] in all cases.
The resulting phase shifts φMM are given in table 5.5 for each patient separately since phase
shifts turned out to differ from patient to patient.
Table 5.5.: Phase shifts φMM estimated according to [Lu et al., 2006a] for Anzai versus VisionRT
(φAVMM), Anzai versus fluoroscopy (φ
AF
MM), and VisionRT versus fluoroscopy (φ
VF
MM).
ID Cases φAVMM [ms] φ
AF
MM [ms] φ
VF
MM [ms]
Min Max Mean Min Max Mean Min Max Mean
1 15 −865 −99 −500 29 137 77 503 984 691
2 1 −49 −49 −49
3 29 −321 383 −22
4 4 64 85 75 4 12 8
5 3 53 119 77
In several motion trajectories base-line drifts were observed which incidence was also patient
specific. While Anzai showed in most cases constant signals and, except for one case, only drifts
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Figure 5.5.: Representative plot of measured and extracted motion traces. Time scale of flu-
oroscopy data is scaled based on a frame rate of 12.5 fps. Amplitudes are scaled
differently to be able to distinguish between the four graphs.
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Figure 5.6.: Exemplary results for the extrema evaluation. The plot shows one VisionRT trajec-
tory overlaid with markers at the detected minima and maxima positions. The red
line represents the mean local amplitude and the purple line the resulting base-line
drift corrected (normalized) trajectory.
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and jumps when other signals also drifted or jumped, for VisionRT and fluoroscopy base line
drifts or jumps could be observed while corresponding signals stayed constant. As an example
in figure 5.7 jumps are shown for Anzai, VisionRT and fluoroscopy.
Figure 5.7.: Examples for cases with sudden jumps. (a) Jump in VisionRT and Anzai signal. (b)
Jump only in fluoroscopy signal while Anzai signal stays constant.
Base-line drifts or jumps could be successfully removed by normalizing trajectories with re-
spect to local amplitude. In figure 5.6 besides the already mentioned indicators for minima,
maxima and mean amplitude the normalized trajectory is plotted.
For the same case in figure 5.8 normalized and original trajectories are shown uncorrected,
corrected by the phase shifts determined based on minima and maxima φMM and corrected by
the phase shift resulting for a maximum CC between the two signals φCC. As in figure 5.8, in all
cases correction by φMM leads to a good matching of the extrema of the different trajectories. In
almost all cases φCC differs from φMM by less than 250ms which indicates that the phase shift
estimation based on the minima and maxima worked very well.
For the analysis of VisionRT signals without beam status information in all cases the corre-
lation coefficient of VisionRT versus Anzai CCNB-A showed a global maximum while for the CC
of VisionRT versus fluoroscopy CCNB-F a global minimum could be found. In most cases the
corresponding shifts between VisionRT and the two other signals, φNB-ACC and φ
NB-F
CC , differed by
less than 410ms. This indicates that the found shift φNB-AFCC based on the best correlation in
respect of both signals (maximum of CCNB-A + |CCNB-F|) represents a clear matching position.
Such a distinct case is exemplarily shown in figure 5.9 in the upper row: in (a) the two corre-
lation coefficients CCNB-A and CCNB-F are plotted showing a global maximum in the former case
and a global minimum in the latter case which are located at the same position. (b) shows the
correspondingly shifted trajectories which lie upon each other due to the little differing shifts
φNB-ACC , φ
NB-F
CC , and φ
NB-AF
CC .
5.3. Results 83
Figure 5.8.: Phase shift corrected breathing signals. The VisionRT signal is plotted at original
position as well as shifted by φMM and φCC. Since the difference between the two
shifts is very low (−9ms in (a) and 46ms in (b)) the two latter plots (blue and pur-
ple graphs) are lying upon each other. (a) Original motion traces. (b) Normalized
signals.
In three cases φNB-ACC and φ
NB-F
CC differ more than 2 s. The worst case in this context is shown in
figure 5.9 in the lower row: In (c) again the two correlation coefficients are plotted showing a
difference of 28.8 s between φNB-ACC and φ
NB-F
CC . Since at the position of φ
NB-A
CC the second largest
minimum of CCNB-F is located and the maximum of CCNB-A at φNB-ACC is much larger than the
maximum of the same CC at CCNB-F also φNB-AFCC results at the same position as φ
NB-A
CC . The plot
of the motion traces shifted by φNB-ACC , φ
NB-F
CC , and φ
NB-AF
CC in figure 5.9(d) shows that a shift of
φNB-AFCC results in a well matching trajectory.
The resulting correlation coefficients for uncorrected, phase shift corrected, and base line
corrected trajectories are summarized in table 5.6. Detailed results for each patient can be
found in the appendix (section A.3).
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Figure 5.9.: Matching result for VisionRT cases without beam status for a clearly matching case
(upper row) and the case with largest difference between φNB-ACC and φ
NB-F
CC (upper
row). (a) Correlation coefficients of VisionRT versus Anzai and VisionRT versus flu-
oroscopy. φNB-ACC ,φ
NB-F
CC and φ
NB-AF
CC are almost equal (differences below 50ms). (b)
Motion traces shifted by the corresponding values shown in (a). The three motion
traces of VisionRT are lying upon each other. (c) Correlation coefficients for the
worst matching case: φNB-ACC and φ
NB-F
CC differ by 28.8 s. (d) Shifted motion signals
for the worst matching case. The purple trajectory differs from the blue and green
curves resulting from the large differences between the corresponding shifts.
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Table 5.6.: Summary of the correlation results. For each type of correlation the number of avail-
able cases is given. The numbers in parentheses include also cases where no beam
status was available in the VisionRT system, but matching based on the CC worked.
For normalized and non-normalized motion traces the CC as well as the phase shift
corrected CCs based on φMM and φCC are given. |CC|NBCC represents the correlation
results for VisionRT cases without beam status.
Type Cases |CC| |CC|MM |CC|CC |CC|
NB
CC |CC|
Norm
MM |CC|
Norm
CC
A vs. V 17 (38) Min 0.01 0.01 0.04 0.58 0.64 0.67
Max 0.97 0.98 0.98 1.00 0.96 0.99
Mean 0.43 0.64 0.65 0.96 0.81 0.83
A vs. F 38 Min 0.36 0.37 0.48 0.48 0.75
Max 0.95 0.95 0.95 0.97 0.98
Mean 0.73 0.73 0.78 0.89 0.92
V vs. F 3 (24) Min 0.19 0.35 0.49 0.29 0.73 0.76
Max 0.47 0.80 0.82 0.92 0.81 0.84
Mean 0.29 0.57 0.57 0.71 0.78 0.81
5.4 Discussion
5.4.1 Gating delays
In two experiments gating delays of the VisionRT system and the Anzai system were per-
formed showing clear differences in the results. Measured gating delays of the VisionRT system
turned out to be higher than for the Anzai system (45ms to 265ms for VisionRT compared to
42ms to 165ms for Anzai – compare table 5.3 and table 5.2). This behaviour was expected
since the sampling intervals of the two systems differ (74ms to 80ms for VisionRT compared
to 25ms for Anzai). But the difference between the mean delays is lower than the difference
between the sampling intervals. This may be due to a faster processing of the acquired data by
the VisionRT system. Behaviour of the VisionRT system, in addition, turned out to be calibra-
tion dependent. A change of the sampling intervals was observed after redoing calibration and
tracking point definition. Thus, calibration has to be done carefully. The maximum measured
gating delay of the VisionRT system is 100ms larger than the maximum delay measured using
the Anzai system. However, even a mean delay of about 100ms (corresponding to 12° for a pe-
riod of 3 s) resulting for the Anzai system can change the dosimetric outcome as the dosimetric
phase shift measurements show.
These results seem to differ from expectations. In case of gating the beam is switched on
when the target is within the target volume. For a phase shift of 180° between motion signal
and actual motion, the beam is switched on when the target centre is maximum distant from the
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target volume centre. If the target volume is small compared to the motion, this would result in
a worst dose distribution for a phase shift of 180°. In our case the target motion of 20mm peak-
to-peak was small compared to the target volume size of (50× 50× 50)mm3. In addition, the
sensitive volumes of the pinpoints were distributed in the left 2/3 of the target. Therefore, also
for a phase shift of 180° all 20 pinpoints stay within the target volume during motion. Thus,
dosimetric results vary based on the interplay effect caused by the effective residual motion.
The gating window size in terms of motion phases was equal for all phase shift measurements.
Since depending on the applied phase shift, the velocity within the gating window changes,
the resulting residual motion amplitude changes, too. Therefore, the largest effective residual
motion is reached for a phase shift of 90° (and, of course, 270°). This is why the dose results
show the worst interplay pattern for a phase shift of 90° and the result for 180° is comparable
to the ones around 0°.
Gating delay estimation based on the measured phase shifts by comparison to simulations
resulted in a delay of 11° corresponding to 92ms which is reasonable compared to the mean
Anzai delays of about 100ms. Taking this shift into account measurements and calculations
match very well.
For patient irradiations a correction for gating delays can be done based on the mean breath-
ing period. Since breathing behaviour of a patient can easily change during a treatment session
an online adaptation of the GW to correct for gating delays may be a better solution which is,
however, not possible with both systems.
5.4.2 Correlation
Preparation experiments for the correlation study showed that temporal correlation of the sig-
nals is doable and the frame rate could successfully be analyzed since motion extraction worked
for the phantom.
Correlation analysis of patient data showed very heterogeneous results. Correlation coeffi-
cients differ depending on patient, fraction and field number which was also found by other
groups [Hoisak et al., 2004; Ionascu et al., 2007]. Two reasons for that could be identified by
the analysis shown above:
Since extrema determination worked very well phase shifts could be successfully estimated.
These phase shifts turned out to be very patient specific. Especially for patient 1 large shifts up
to 1 s occurred between VisionRT and the Anzai system while for patient 4 this shift was signifi-
cantly lower. Also the phase shift between the Anzai system and fluoroscopy varied depending
on the patient. Observed phase shifts match to values for comparison of other motion sensors
found in the literature [Ionascu et al., 2007; Otani et al., 2010; Tsunashima et al., 2004]. A
reason for these shifts may be the position of data acquisition. In this study the area around
the sternum was the basis for motion tracking using the VisionRT system while the Anzai belt
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for patient 1,2,4, and 5 was measuring at the abdominal region. In case of patient 3 due to the
used abdominal compression the Anzai belt also measured breast motion. It is reasonable that
during breathing a phase shift between breast breathing and abdominal respiration can occur
and that internal motion may higher correlate to the abdominal motion since the diaphragm
is mainly causing the lung motion. For the five patients phase shifts of the Anzai system were
small in case of measuring abdominal motion and large in case of measuring breast motion. For
the VisionRT system phase shifts were large for one patient and low for the second one (patient
4) where beam status information was available. This difference can also be seen for the Anzai
belt where phase shifts were smallest for patient 4.
Base line drifts were found in all types of observed signals. The Anzai system showed the
smallest drifts even when internal motion showed large ones. Base line drifts may be caused by
muscle relaxation which e. g. was reported by [von M. Siebenthal et al., 2007b].
Correction of the signals with respect to base line drifts worked also very well and the resulting
increased correlation coefficients show that a base line drift also influences the correlation.
Correlation coefficients of Anzai versus VisionRT ranged from 0.01 to 0.97 (table 5.6; |CC|) in
the uncorrected calculation which strongly depends on patient, but also phase shift and base-
line drift. If signals are corrected for both influences (|CC|NormMM ) the correlation coefficient rises
significantly in most cases. Also the comparison of the Anzai signals with the VisionRT signals
without beam status showed that there seem to be a high correlation in almost all cases (|CC|NBCC).
This data can not be compared directly to reported data from the literature. But there are two
publications comparing the Anzai system and the VisionRT system, respectively, to the RPM
system. [Otani et al., 2010] found CCs ranging from 0.94 to 0.99 for Anzai versus RPM and
[Hughes et al., 2009] reported a CC of 0.62 to 0.96 for VisionRT versus RPM.
For VisionRT versus fluoroscopy only three cases were measured with beam status signal and
a low CC was found (0.19 to 0.47). Also here a strong dependency on phase shift and base-line
drift can be seen which indicates also a dependency on the tracking point position as mentioned
above. Since the VisionRT system so far was not investigated with respect to correlation to
internal motion, results may be compared to correlation coefficients published by [Koch et al.,
2004] who studied correlation of surface motion to internal motion based on MRI. They found
a CC ranging from 0.58 to 0.9 with strong dependence on the chosen surface marker which
corresponds to the tracking point position on the thorax surface.
The Anzai system correlates a little better with the internal motion than the VisionRT system.
CCs ranging from 0.36 to 0.95 were found (table 5.6) which are comparable to the results of
[Ionascu et al., 2007] who computed the correlation of the Anzai system to kV-fluoroscopy and
reported a CC of 0.77 to 0.88. However, they used the Anzai laser while we used the pressure
belt which may have implications on the result. If signals are corrected for phase shifts and
base-line drifts only slightly higher CCs remain for the Anzai versus fluoroscopy compared to
VisionRT versus fluoroscopy. This also indicates that the correlation may have something to do
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with differences in breast breathing and abdominal respiration which may cause these shifts
and drifts and may have more effect on the VisionRT system if the tracking point is set to the
sternum region.
In summary, the Anzai system showed lower gating delays than the VisionRT system which
is reasonable due to the lower sampling interval. But according to that interval even smaller
delays would have been expected for the Anzai system. All found delays are too little to affect
geometrical mismatch of the tumour but it was shown that the dose interplay pattern may
change due to a change residual motion. If a maximum short gating delay has highest priority
the Anzai system would be the preferred system.
With respect to correlation coefficients no clear judgement can be made. It was shown that
differences between the correlation of Anzai versus fluoroscopy and VisionRT versus fluoroscopy
may mainly be caused by phase shifts and base-line drifts. Both effects seem to correlate more
to the abdominal motion. The position of the skin area used for motion tracking appears to be
important for both systems to gain a good internal-external correlation.
Since the VisionRT system offers more complex functionality than the Anzai system it is more
sensitive to external influences. Therefore, calibration has to be done accurately and an ap-
propriate tracking point has to be chosen which optimal position has to be investigated in the
future. Both systems can show very short gating delays as well as very high correlation coef-
ficients. Especially the correlation coefficients of Anzai versus VisionRT were high in most (at
least phase shift corrected) cases. Therefore, differences between the two systems can be small
if they are used appropriate.
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6 Comprehensive discussion and future
prospects
Gating will most likely be the first technique used for the treatment of liver patients at Hei-
delberg Ion-Beam Therapy Center (HIT). However, several issues have to be clarified before
starting patient treatment with gated irradiation using a scanned ion-beam.
One of these aspects is the problem of residual motion. Gating implies an extension of the
treatment time by up to a factor of 5 [Tsunashima et al., 2008]. Longer treatment time can result
in lower treatment precision [von M. Siebenthal et al., 2007a,b] and is less comfortable for the
patient. Furthermore, the total number of per day treatable patients shrinks which leads to an
undesirable lower cost-efficiency. Therefore, the increase of treatment time due to gating should
be as small as possible which implies a reasonably large gating window (GW). Motion within
the GW is reduced, but not vanished. Since even small motion can lead to severe under and
over dosage in the target volume due to the interplay effect [Bert et al., 2008; Groezinger et al.,
2006; Lambert et al., 2005; Phillips et al., 1992] appropriate techniques to mitigate motion
effects within the GW are needed.
According to [Bert et al., 2009] an increased overlap of the single beam spots, laterally and
longitudinally, can be a solution for this problem at least for a 1D motion and with respect to
film dosimetry. To bring this approach closer to clinical application more complex motion and a
larger number of beam parameters which lead to the overlap of the single beam spots had to be
studied. In addition, 3D absolute dosimetry had to be investigated, an instrument usually used
for treatment plan verification in radiation therapy [Karger et al., 1999].
This study was performed in the course of this work (chapter 3): Lateral grid spacing, beam
focus size, iso-energy slice (IES) distance, and Bragg-peak width (via different ripple filters
[Weber and Kraft, 1999]) were varied and the dosimetric effects on a target moving in 3D
depending on the residual motion amplitude (corresponding to a certain GW) were investigated.
Since the parameter space was very large and the measurement time limited simulations were
performed introducing more residual motion amplitudes and motion starting phases.
Results showed that for the lateral overlap increasing the beam focus lead to very good mit-
igation of residual motion consequences in terms of homogeneity while decreasing the lateral
grid spacing resulted only in little effects. Thus, increasing the beam focus is more efficient
than decreasing the lateral grid spacing. However, when increasing the focus size one has to
be aware of the larger penumbra resulting in a higher dose to normal tissue. Reducing the IES
distance also proved to be an effective possibility to gain better homogeneity while variation
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of the ripple filter does not show significant effect. The latter finding may be due to the little
difference between the two used filters.
In parts the results were already used for patient irradiations: in the non-gated treatments
of liver patients at HIT which were started this year a larger focus size was used to mitigate
effects of tumours with small motion. Beyond that the results may show the possibility of
reducing the treatment time: Irradiation time strongly depends on the number of IES since for
each slice the particles have to be accelerated to the desired energy which at HIT takes a few
seconds. In addition, irradiation time of a certain slice depends on the number of raster points.
Since the beam focus size turned out to be more important than the overlap, a larger focus in
combination with larger grid spacing may lead to sufficient results. Larger grid spacing results
in a lower number of raster points which usually reduces the irradiation time. Thus, besides
mitigating residual motion effects the results from this study may help to reduce treatment
time. However, these effects should be validated in treatment plan studies based on real patient
data. Furthermore, the timing implications are only true for synchrotron based treatment sites
like GSI or HIT. For systems with passive energy variation irradiation time does not depend
so much on the number of IES due to the much faster energy variation capability [Pedroni
et al., 2004]. In addition, there is one synchrotron based scanning system at National Institute
of Radiological Sciences (NIRS) which is capable of applying dose so fast [Furukawa et al.,
2010b] that a reduced raster position number may not have any effect. Anyhow, for the patient
treatments at HIT and similar facilities improvements can be made based on the results.
But only adapting beam parameters with the aim to mitigate residual motion effects is not
sufficient to result in a satisfactory dose distribution. It has to be ensured that the target is
within the target volume when the beam is switched on. Therefore, an appropriate motion
monitoring system is necessary to be able to gate the beam depending on the target’s position.
To avoid additional dose to the patient by using direct monitoring via fluoroscopy [Shirato et al.,
2004] application of surrogate signals (e. g. thorax motion) were proposed [Evans, 2008]. But
if a surrogate is used it is important that the surrogate motion correlates with the actual target
motion. Unfortunately, this correlation depends on the patient and can change even for one
patient within one treatment session [Hoisak et al., 2004; Ionascu et al., 2007; Koch et al.,
2004]. Therefore, systematic phantom studies of miscorrelations are necessary to determine
dosimetric effects of base-line drifts, phase shifts and irregular motion.
In the course of this work a phantom was designed, built and validated. Initially the phan-
tom was constructed for dosimetric correlation studies using a scanned ion beam. Therefore,
amongst other parameters it should be capable to perform independent internal and external
motion with fixed or variable dedicated correlation as patient realistic as possible. The built
phantom consists of a breathing thorax including ribs and a target which can be moved in-
dependently in all six degrees of freedom (3 translation, 3 rotation) by a robotic arm while
correlation between these two motions is adjustable. Validation experiments showed that the
92 6. Comprehensive discussion and future prospects
phantom can be used for dosimetry studies based on 20 ionization chambers distributed over the
moving target volume. Furthermore, radiographic films offer the possibility to measure target
dose homogeneity with a higher spatial resolution compared to the ionization chamber array.
The phantom was successfully tested in several experiments and used in the third part of this
work for investigating dosimetric effects of dedicated phase shifts between internal and external
correlation. However, there is some room for improvement where two major aspects shall be
mentioned: The first affects the intra-lung material. At the moment the lung is filled with air
which results in a non-realistic density. Appropriate foam (e. g. polyurethane (PU)) might be
inserted to introduce tissue equivalent range changes within the lung. The second improvement
can be done on the thorax motion control. So far only the target can do irregular motion. Using
a new more elaborate motion controller more realistic breathing motion trajectories may be
introduced to also get closer to realistic patient breathing signals.
Thus, a very flexible complex motion phantom is now available which is the basis of future
correlation studies for gated irradiations. But beyond that, more possible fields of application
exist. Focussing on ion irradiation there are also other motion mitigation techniques which
rely on motion monitoring and/or could also be tested in a more complex phantom than the
water phantom which is used in our group. Beam tracking [Groezinger et al., 2004] and its
new implementations [Lüchtenborg et al., 2011] can be candidates as well as implementations
of breathing synchronized flavours of rescanning [Furukawa et al., 2010a]. The phantom was
designed for the use with carbon ions, but it can also be used for photon or proton irradiations.
Testing of new techniques for beam tracking using photons [Schweikard et al., 2004] may be
a field of application as well as dosimetric validation of motion prediction techniques [Hoisak
et al., 2006; Kanoulas et al., 2007; Schweikard et al., 2004; Spadea et al., 2010]. Baroni et al.
are currently using the phantom for testing their prediction methods during a beam time at GSI.
Furthermore, ideas came up to use the phantom for 4D imaging validation purposes. Usage with
magnetic resonance imaging (MRI) is not possible due to the metal components, but validation
experiments for 4D position emission tomography (PET) which can be used for verification of
treatment delivery in ion therapy [Parodi et al., 2005, 2007] are performable using the phantom.
The target holder can easily be equipped with a target appropriate for PET. This flexibility in
respect of target detector implies that the phantom can also be used for biological experiments
such as cell survival measurements as performed by [Gemmel et al., 2010].
One further application of such a phantom can be the investigation of different motion mon-
itoring systems. Plenty of sensors are commercially available monitoring different surrogate
quantities. Two of such sensors are available at the university clinic Heidelberg where HIT
belongs to. When introducing new beam delivery techniques for patient treatments where a
motion monitoring system is mandatory, the question arises which motion monitoring system
has optimal performance. Thus, two sensors, the VisionRT system (AlignRT®/GateRT®– Vi-
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sionRT Ltd., London, UK) and the Anzai system (RGS AZ-733V – Anzai Medical Co.,Ltd, Tokyo,
Japan), were investigated in the course of this work (chapter 5).
Besides estimation of gating delays caused by the signal processing of the two systems patient
data was analysed in respect of correlation of the systems to internal tumour motion. This
internal motion was acquired using MV-fluoroscopy during normal photon treatment to avoid
introduction of additional dose to the patient. Results showed that gating delays of the VisionRT
system are larger than for the Anzai system which is reasonable due to the larger sampling
interval. In the patient data both systems showed phase shifts, base line drifts or even sudden
jumps in the motion signal leading to lower correlation coefficients. Both systems showed in
some cases very good correlation to the internal motion while in other cases the situation turned
out to be worse. Results gave the impression that phase shifts may depend on the position
where the external motion signal is acquired: Breast motion seems to be phase shifted from
abdominal motion. In general no difference between the two systems related to correlation
can be derived from the results. However, results are only based on the data of 5 patients.
More data would be necessary to generalize the conclusions drawn from these results. The
VisionRT system offers much more flexibility compared to the Anzai system e. g. in terms of
tracking point selection. Therefore, it is necessary to use this flexibility in the right way to
take advantages from that. In this context an investigation of the dependencies of the VisionRT
tracking point on correlation results may be interesting to investigate. The current version
of the phantom which was developed, built and validated in the course of this work offers the
possibility to further investigate motion sensors. At HIT the Anzai system will be used for patient
irradiations, but there are also plans to install a VisionRT system in the treatment rooms since it
is also capable of assisting in patient setup.
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7 Summary
About 50% of cancer patients are treated with radiation therapy. A special flavour of this
treatment type is particle therapy which offers the potential of higher biological effectiveness
and increased sparing of normal tissue due to better target conformity. The latter advantage can
further be increased by using a special delivery technique: the 3D pencil beam scanning. In this
technique numerous beam spots overlap laterally and Bragg-peaks overlap longitudinally to a
homogeneous dose distribution if beam parameters are set appropriately. For stationary tumours
patient treatment using particle therapy was very successful. However, if tumours are located
in organs affected by motion (e. g. due to respiration) the situation gets more complicated. In
addition to the geometrical displacement range changes and the interplay effect (in case of
scanned beams) have to be taken into account to accomplish satisfactory dose distributions.
One technique to mitigate target motion effects is gating which means pausing the irradia-
tion while the tumour is outside the target volume. This approach increases treatment time,
but decreases the effective motion amplitude. However, even for a small residual motion the
interplay effect can cause inhomogeneous dose distributions. To mitigate this a beam parameter
study was performed in the course of this work to investigate how changes of beam parameters
effect the resulting dose distribution. In measurements and simulations 18 beam parameter
combinations for up to 10 residual motion amplitudes and several starting phases were inves-
tigated. Results show that increased beam focus size highly increase homogeneity of the target
dose while reduction of the distance between the beam spots doesn’t. Thus, beam focus size
is more important than the actual overlap. Longitudinally using smaller distances between the
overlapping Bragg-peaks also increased homogeneity in the target volume.
To ensure that the tumour is within the target volume while the dose is delivered appropriate
motion monitoring systems are needed. Often surrogates are used for which a correlation to the
actual motion is essential. To provide a setup to investigate dosimetric effects of miscorrelation
in this work a complex moving thorax phantom was designed, constructed and validated. 6D
tumour motion can be performed independently from thorax motion. The phantom comprises
ribs to generate range changes and an ionization chamber array as well as multiple films for
target dose measurements. Basic functionality and capability of absolute dose measurements
were successfully validated.
As mentioned above correlation of surrogate and internal motion is important and, further-
more, short reaction times are needed to ensure that the beam is gated correctly synchronized
to the target motion. To investigate these issues two commercially available motion monitoring
systems, the VisionRT system and the Anzai system were compared in the third part of this work.
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Gating delays were estimated experimentally and for 5 patients correlation between surrogate
motion and internal tumour motion was studied. Gating delays of the VisionRT system turned
out to be higher than for the Anzai system. In respect of correlation no basic difference between
the two systems can be concluded. The VisionRT system is more complex than the Anzai system
which increases the application possibilities, but also the requirements to the user.
In summary in this work several aspects were investigated and knowledge was gained to get
closer to the first gated patient treatment at HIT. First patient treatments of liver tumours that
were motion constrained by abdominal compression were performed at HIT using knowledge
gained from the beam parameter study. At first the Anzai system will be used for gating, but
there are plans to also install a VisionRT system in the treatment rooms. Furthermore, due to the
new phantom now an instrument is available which can be used in various fields of application
in conjunction with moving target irradiation or imaging. The phantom was already used in the
course of this work. Moreover first studies of internal and external groups are planned or in
progress using the new phantom.
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A Supplementary details on the sensor
evaluation results
A.1 Gating delays of the Anzai system
Table A.1.: Measured gating delays of the Anzai system. Besides the number of gating win-
dows (NGW) which were analysed per measurement the mean, standard deviation
(SD), minimum and maximum of the start delay ∆tStart and the stop delay ∆tStop,
respectively, are given.
# NGW ∆tStart ∆tStop
Mean SD Min Max Mean SD Min Max
[ms] [ms] [ms] [ms] [ms] [ms] [ms] [ms]
1 68 68 8 46 78 74 10 58 87
2 91 137 14 117 156 90 11 75 126
3 105 103 12 82 131 104 9 91 143
4 87 119 11 107 146 136 10 102 152
5 90 108 10 92 124 119 8 108 138
6 95 109 6 92 131 119 10 103 135
7 63 138 7 131 165 142 5 117 149
8 66 99 6 91 114 102 10 89 121
9 87 59 10 44 77 59 10 42 75
10 85 80 6 63 102 93 10 76 112
11 63 99 9 80 112 102 8 93 122
12 59 89 11 78 112 104 5 81 113
13 61 84 8 76 105 89 8 81 113
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A.2 Gating delays of the VisionRT system
Table A.2.: For each day and measurement the number of gating windows (NGW), the mean and
standard deviation (SD) of the sampling interval (SaI) and the mean, the standard
deviation (SD), the maximum and minimum start ∆tStart and the stop delay ∆tStop,
respectively, is listed.
Day # NGW SaI ∆tStart ∆tStop
Mean SD Mean SD Min Max Mean SD Min Max
[ms] [ms] [ms] [ms] [ms] [ms] [ms] [ms] [ms] [ms]
1 1 116 78 10 165 26 108 250 181 30 125 260
1 2 120 80 11 160 31 93 256 136 28 82 229
1 3 99 81 12 153 31 100 245 136 24 89 180
1 4 113 80 11 174 33 112 265 152 25 100 236
1 5 102 81 12 166 28 112 251 147 26 91 226
1 6 90 81 12 152 31 93 240 130 27 75 223
1 7 99 81 12 164 30 109 253 143 28 86 216
1 8 101 80 11 162 27 102 249 140 28 83 220
1 9 100 81 12 162 27 109 250 136 26 87 195
1 10 98 81 12 164 32 111 259 139 28 89 227
2 1 97 74 2 112 23 70 158 100 21 63 136
2 2 100 74 2 115 23 75 174 100 21 63 138
2 3 103 74 2 117 22 71 164 128 22 88 165
2 4 113 75 3 134 24 89 188 141 24 98 201
2 5 90 75 5 130 25 77 182 138 22 98 176
2 6 99 75 6 136 25 87 188 144 23 102 190
2 7 99 75 5 117 23 71 177 124 23 80 168
2 8 108 74 4 110 23 60 165 123 22 82 163
2 9 117 74 2 101 23 54 148 118 22 77 155
3 1 112 74 2 125 22 81 168 115 22 76 153
3 2 81 74 2 117 22 79 156 105 22 67 147
3 3 98 74 3 127 22 84 170 113 21 74 151
3 4 94 74 3 112 22 72 158 103 21 65 143
3 5 85 74 2 128 22 88 168 115 22 76 155
3 6 87 74 1 99 22 59 139 87 22 45 127
3 7 84 74 3 115 22 73 156 102 22 63 144
Continued on next page
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Table A.2 – continued from previous page
Day # NGW SaI ∆tStart ∆tStop
Mean SD Mean SD Min Max Mean SD Min Max
[ms] [ms] [ms] [ms] [ms] [ms] [ms] [ms] [ms] [ms]
3 8 83 74 2 118 22 75 159 103 22 62 143
4 1 96 74 2 131 23 88 175 125 21 87 164
4 2 107 74 3 133 23 89 177 125 21 90 162
4 3 105 74 1 135 22 93 175 129 22 87 171
4 4 119 74 3 124 22 82 163 119 22 81 163
4 5 118 74 1 121 23 77 167 115 22 72 156
4 6 106 74 3 138 23 93 181 131 22 89 174
4 7 105 74 2 128 22 86 170 122 21 82 159
4 8 93 74 3 146 23 103 195 138 22 102 196
4 9 94 74 2 134 23 90 180 130 21 91 167
4 10 104 74 3 132 22 91 170 125 21 86 169
4 11 114 74 3 138 22 98 185 130 22 89 170
5 1 102 78 9 125 27 66 189 137 26 81 209
5 2 112 79 10 120 24 69 174 140 27 86 223
5 3 103 79 10 126 27 71 230 145 25 95 226
5 4 95 79 10 141 26 86 193 158 28 103 244
5 5 99 79 10 141 26 91 212 160 28 109 256
5 6 95 78 10 131 24 77 195 155 30 99 250
5 7 87 78 10 134 25 87 194 160 28 106 247
5 8 96 79 11 127 24 80 192 146 28 93 224
5 9 91 78 10 127 25 82 177 149 28 93 238
5 10 104 79 10 121 25 78 172 142 28 90 224
5 11 107 78 10 127 25 82 188 152 29 96 232
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A.3 Correlation coefficients
Table A.3.: Correlation coefficients (CC) for Anzai versus VisionRT. For normalized and non-
normalized motion traces the CC as well as the phase shift corrected CCs based
on φMM and φCC are given. |CC|NBCC represents the correlation results for VisionRT
cases without beam status.
PatID Fraction Field A V F |CC| |CC|MM |CC|CC |CC|
Norm
MM |CC|
Norm
CC |CC|
NB
CC
1 1 1 Ø Ø −0.42 −0.01 0.04 0.79 0.8
1 1 2 Ø Ø 0.35 0.77 0.78 0.8 0.79
1 1 3 Ø Ø −0.01 0.64 0.67 0.86 0.87
1 1 4 Ø Ø 0.28 0.72 0.72 0.85 0.86
1 1 5 Ø Ø Ø 0.06 0.68 0.7 0.73 0.73
1 2 1 Ø Ø 0.24 0.41 0.43 0.88 0.88
1 2 2 Ø Ø 0.79 0.81 0.81 0.88 0.92
1 2 3 Ø Ø 0.09 0.11 0.15 0.7 0.73
1 2 4 Ø Ø 0.6 0.62 0.65 0.75 0.77
1 2 5 Ø Ø Ø 0.11 0.41 0.44 0.76 0.78
1 3 1 Ø Ø 0.8 0.84 0.84 0.81 0.82
1 3 2 Ø Ø 0.32 0.76 0.76 0.64 0.67
1 3 3 Ø Ø 0.23 0.67 0.66 0.82 0.83
1 3 4 Ø Ø 0.69 0.83 0.8 0.82 0.85
1 3 5 Ø Ø Ø 0.44 0.7 0.72 0.86 0.86
2 1 6 Ø (Ø) Ø 0.58
3 1 4 Ø (Ø) Ø 0.99
3 1 5 Ø (Ø) Ø 0.99
3 1 6 Ø (Ø) Ø 0.98
3 1 7 Ø (Ø) Ø 0.99
3 2 4 Ø (Ø) Ø 1.00
3 2 6 Ø (Ø) Ø 0.99
3 2 7 Ø (Ø) Ø 0.99
3 3 4 Ø (Ø) Ø 0.99
3 3 5 Ø (Ø) Ø 0.98
3 3 6 Ø (Ø) Ø 0.99
3 3 7 Ø (Ø) Ø 0.99
3 4 4 Ø (Ø) Ø 0.99
Continued on next page
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Table A.3 – continued from previous page
PatID Fraction Field A V F |CC| |CC|MM |CC|CC |CC|
Norm
MM |CC|
Norm
CC |CC|
NB
CC
3 4 5 Ø (Ø) Ø 0.99
3 4 6 Ø (Ø) Ø 0.98
3 4 7 Ø (Ø) Ø 0.93
3 5 4 Ø (Ø) Ø 0.98
3 5 5 Ø (Ø) Ø 0.96
3 5 6 Ø (Ø) Ø 0.96
3 5 7 Ø (Ø) Ø 0.93
4 1 5 Ø Ø 0.97 0.98 0.98 0.96 0.99
4 1 6 Ø Ø 0.96 0.98 0.98 0.94 0.98
5 1 3 Ø (Ø) Ø 0.90
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Table A.4.: Correlation coefficients (CC) for Anzai versus fluoroscopy. For normalized and non-
normalized motion traces the CC as well as the phase shift corrected CCs based on
φMM and φCC are given.
PatID Fraction Field A V F |CC| |CC|MM |CC|CC |CC|
Norm
MM |CC|
Norm
CC
1 1 5 Ø Ø Ø −0.64 −0.66 −0.72 −0.97 −0.97
1 2 5 Ø Ø Ø −0.75 −0.75 −0.76 −0.96 −0.97
1 3 5 Ø Ø Ø −0.92 −0.93 −0.94 −0.96 −0.98
2 1 6 Ø (Ø) Ø −0.9 −0.9 −0.92 −0.9 −0.93
3 1 2 Ø Ø −0.92 −0.92 −0.93 −0.92 −0.94
3 1 3 Ø Ø 0.46 0.48 −0.79 0.48 −0.82
3 1 4 Ø (Ø) Ø −0.7 −0.73 −0.82 −0.95 −0.95
3 1 5 Ø (Ø) Ø −0.87 −0.87 −0.89 −0.89 −0.91
3 1 6 Ø (Ø) Ø −0.53 −0.53 −0.51 −0.85 −0.87
3 1 7 Ø (Ø) Ø −0.87 −0.88 −0.9 −0.93 −0.96
3 2 2 Ø Ø −0.93 −0.93 −0.93 −0.93 −0.94
3 2 3 Ø Ø −0.95 −0.95 −0.95 −0.96 −0.98
3 2 4 Ø (Ø) Ø −0.65 −0.7 −0.74 −0.95 −0.96
3 2 6 Ø (Ø) Ø −0.65 −0.62 −0.62 −0.9 −0.92
3 2 7 Ø (Ø) Ø −0.68 −0.68 −0.67 −0.91 −0.94
3 3 2 Ø Ø −0.68 −0.68 −0.75 −0.92 −0.96
3 3 3 Ø Ø −0.71 −0.68 −0.79 −0.9 −0.97
3 3 4 Ø (Ø) Ø −0.69 −0.72 −0.77 −0.89 −0.89
3 3 5 Ø (Ø) Ø −0.54 −0.53 −0.61 −0.84 −0.83
3 3 6 Ø (Ø) Ø −0.91 −0.91 −0.92 −0.93 −0.93
3 3 7 Ø (Ø) Ø −0.77 −0.79 −0.8 −0.93 −0.94
3 4 2 Ø Ø −0.59 −0.59 −0.74 −0.81 −0.89
3 4 3 Ø Ø −0.9 −0.92 −0.94 −0.95 −0.96
3 4 4 Ø (Ø) Ø −0.71 −0.78 −0.8 −0.92 −0.92
3 4 5 Ø (Ø) Ø −0.64 −0.64 −0.61 −0.84 −0.86
3 4 6 Ø (Ø) Ø −0.85 −0.82 −0.87 −0.86 −0.94
3 4 7 Ø (Ø) Ø −0.83 −0.64 −0.85 −0.63 −0.93
3 5 2 Ø Ø −0.85 −0.87 −0.88 −0.89 −0.9
3 5 3 Ø Ø −0.84 −0.9 −0.91 −0.92 −0.93
3 5 4 Ø (Ø) Ø −0.8 −0.8 −0.83 −0.88 −0.89
3 5 5 Ø (Ø) Ø −0.63 −0.67 −0.69 −0.75 −0.75
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Table A.4 – continued from previous page
PatID Fraction Field A V F |CC| |CC|MM |CC|CC |CC|
Norm
MM |CC|
Norm
CC
3 5 6 Ø (Ø) Ø −0.55 −0.57 −0.62 −0.8 −0.84
3 5 7 Ø (Ø) Ø −0.74 −0.78 −0.82 −0.84 −0.84
4 1 3 Ø Ø −0.85 −0.85 −0.9 −0.94 −0.95
4 1 4 Ø Ø −0.54 −0.54 −0.61 −0.92 −0.93
5 1 2 Ø Ø −0.63 −0.62 −0.7 −0.97 −0.98
5 1 3 Ø (Ø) Ø −0.36 −0.37 −0.48 −0.96 −0.97
5 1 4 Ø Ø −0.65 −0.61 −0.74 −0.93 −0.94
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Table A.5.: Correlation coefficients (CC) for VisionRT versus fluoroscopy. For normalized and
non-normalized motion traces the CC as well as the phase shift corrected CCs based
on φMM and φCC are given. |CC|NBCC represents the correlation results for VisionRT
cases without beam status.
PatID Fraction Field A V F |CC| |CC|MM |CC|CC |CC|
Norm
MM |CC|
Norm
CC |CC|
NB
CC
1 1 5 Ø Ø Ø 0.22 −0.35 −0.49 −0.73 −0.76
1 2 5 Ø Ø Ø −0.47 −0.8 −0.82 −0.8 −0.82
1 3 5 Ø Ø Ø −0.19 −0.55 −0.63 −0.81 −0.84
2 1 6 Ø (Ø) Ø −0.56
3 1 4 Ø (Ø) Ø −0.73
3 1 5 Ø (Ø) Ø −0.86
3 1 6 Ø (Ø) Ø −0.54
3 1 7 Ø (Ø) Ø −0.87
3 2 4 Ø (Ø) Ø −0.69
3 2 6 Ø (Ø) Ø −0.68
3 2 7 Ø (Ø) Ø −0.71
3 3 4 Ø (Ø) Ø −0.71
3 3 5 Ø (Ø) Ø −0.55
3 3 6 Ø (Ø) Ø −0.92
3 3 7 Ø (Ø) Ø −0.79
3 4 4 Ø (Ø) Ø −0.77
3 4 5 Ø (Ø) Ø −0.64
3 4 6 Ø (Ø) Ø −0.85
3 4 7 Ø (Ø) Ø −0.78
3 5 4 Ø (Ø) Ø −0.82
3 5 5 Ø (Ø) Ø −0.70
3 5 6 Ø (Ø) Ø −0.62
3 5 7 Ø (Ø) Ø −0.86
5 1 3 Ø (Ø) Ø −0.29
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